# Chapter 81: Restless Legs Syndrome

## The Biological and Neurological Basis of Restless Legs Syndrome

### Introduction

Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a chronic, often debilitating neurological disorder that profoundly impacts an individual's quality of life (Summerton, 2004; Mansur et al., 2019; Farrer, 2008; Pinder, 2006). Despite its relatively high prevalence in the general population, estimated to affect between 2% and 15% of adults, the condition remains frequently underdiagnosed and misunderstood by both the public and medical professionals (Mansur et al., 2019; Williams, 2011; Massey & Robertson, 2020; Sitaru et al., 1999; Ulfberg et al., 1999; Hyman, 2008). Historically, symptoms have been dismissed as trivial or psychogenic, leading to significant delays in appropriate diagnosis and management (Summerton, 2004; Pinder, 2006; Unknown, 2003). However, a growing body of evidence has firmly established RLS as a distinct sensorimotor disorder with a complex and multifactorial neurobiological basis (Inoue, 2009; Pinder, 2006; Hiestand & Phillips, 2007; Mano & Thomas, 2018).

The diagnosis of RLS is made clinically, based on a set of essential criteria established by the International Restless Legs Syndrome Study Group (IRLSSG) (Walters et al., 1995; Beneš et al., 2007; Volder, 2006). These four cardinal features are: 1) an urge to move the legs, which is usually but not always accompanied by uncomfortable or unpleasant sensations; 2) the urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity, such as sitting or lying down; 3) these symptoms are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues; and 4) the symptoms are worse in the evening or at night, or only occur in the evening or night (Summerton, 2004; Walters et al., 1995; Volder, 2006; Medcalf & Bhatia, 2006; Beneš et al., 2007; Allen, 2012). These criteria highlight the dual nature of the disorder, involving both a sensory component—the dysesthesias—and a motor component—the compelling urge to move, or focal akathisia (Walters et al., 1995; Allen, 2012; Rubí, 2018).

The sensory disturbances are often difficult for patients to describe, with common descriptors including "creepy-crawly," "pulling," "throbbing," "tingling," "burning," or an internal "itch" (Lee-Chiong, 2008; Farrer, 2008; Hiestand & Phillips, 2007; Smith, 2009). These sensations are typically felt deep within the limbs, often between the knee and ankle, rather than superficially on the skin (Lee-Chiong, 2008; Smith, 2009; Schwarz & Trenkwalder, 1996). While usually not described as overtly painful, a complaint of pain does not exclude the diagnosis (Lee-Chiong, 2008; Smith, 2009). The motor component is an irresistible compulsion to move the affected limbs to gain temporary relief (Lee-Chiong, 2008; Ryan & Slevin, 2007). This motor restlessness is a defining feature and differentiates RLS from other conditions involving leg discomfort (Walters et al., 1995; Volder, 2006).

The profound circadian rhythmicity of RLS is a key neurobiological feature, with symptoms characteristically worsening in the evening and at night (Summerton, 2004; Volder, 2006; Bogan, 2006). This diurnal pattern is a primary driver of the sleep disturbances that are a major consequence of the disorder, including sleep-onset insomnia and frequent awakenings (Bogan, 2006; Provini et al., 2008; Castaño-Cárcamo et al., 2014). Studies have suggested that the worsening at rest and the worsening at night are related but separate phenomena, underscoring the complex interplay between activity states and endogenous circadian processes in the expression of RLS symptoms (Walters & Zee, 2023). Furthermore, RLS is closely associated with periodic limb movements of sleep (PLMS), which are repetitive, stereotyped flexor movements of the limbs occurring during sleep in approximately 80% of RLS patients (Williams, 2011; Provini et al., 2008; O’Regan & Anderson, 2020; Sabbineni, 2020).

This chapter will provide a comprehensive examination of the biological and neurological underpinnings of Restless Legs Syndrome. It will delve into the primary neurobiological systems implicated in its pathophysiology, particularly the central dopaminergic pathways and brain iron metabolism. The genetic and molecular basis of the disorder, brain structure and function, and developmental aspects will be explored. Finally, the chapter will discuss the biological mechanisms of current treatments and highlight future directions for research, synthesizing the current understanding of RLS as a complex network disorder of the central nervous system.

### Neurobiological Systems

The pathophysiology of RLS is not yet fully understood, but converging lines of evidence point toward a complex interplay of several neurobiological systems, with central dopaminergic pathways and brain iron metabolism playing principal roles (Pinder, 2006; Massey & Robertson, 2020; Hamdan & Machin, 2009). The remarkable efficacy of dopaminergic agents and the strong association with iron deficiency states have anchored modern research into the biological basis of the disorder (İpekdal et al., 2011; Sławek, 2018). Furthermore, evidence suggests involvement of other neurotransmitter systems, including opioids and glutamate, as well as contributions from both the central and peripheral nervous systems (Perkins et al., 2010; Hong, 2008). This section will explore the key systems implicated in the generation of RLS symptoms.

#### The Dopaminergic System

The most compelling evidence for a primary neurobiological substrate in RLS involves dysfunction within the central nervous system's dopaminergic pathways (Pinder, 2006; Medcalf & Bhatia, 2006; Massey & Robertson, 2020). This "dopamine hypothesis" is supported by several key observations. First and foremost is the consistent and often dramatic therapeutic response to dopaminergic medications, such as levodopa and dopamine agonists (pramipexole, ropinirole), which are considered first-line treatments for moderate to severe RLS (Inoue, 2009; Pinder, 2006; Sławek, 2018; Perkins et al., 2010). A positive response to dopaminergic therapy is even considered a supportive criterion for diagnosis (Inoue, 2009; Provini et al., 2008; Klepitskaya, 2016).

Conversely, drugs that block dopamine receptors (dopamine antagonists), such as many antipsychotics (neuroleptics) and some antiemetics (e.g., metoclopramide, prochlorperazine), are known to precipitate or exacerbate RLS symptoms (Williams, 2011; Raux et al., 2010; Ostroumova et al., 2020; Siemiński & Zemojtel, 2019; Rubí, 2018). This pharmacological evidence strongly suggests that a state of relative dopaminergic deficiency or dysfunction underlies the sensorimotor symptoms of the disorder (Pinder, 2006; Massey & Robertson, 2020).

The specific dopaminergic pathways implicated are thought to involve subcortical structures, particularly the basal ganglia and related circuits (Nambu, 2012; Medcalf & Bhatia, 2006). The basal ganglia, which include the striatum (caudate and putamen), are critical for motor control and processing sensory information (Dodd, 2007; Nambu, 2012). Positron emission tomography (PET) studies have shown a mild but significant reduction of D2 receptor binding in the striatum of RLS patients, suggesting post-synaptic dopaminergic dysfunction (Medcalf & Bhatia, 2006). The five main types of dopamine receptors (D1-D5) are distributed differently throughout the brain; D2 receptors are highly concentrated in the striatum, while D3 and D4 receptors are found in high concentrations in the limbic system, and D5 receptors are located in the thalamus and hippocampus (Dodd, 2007). The dysfunction in RLS may specifically relate to hyperactivity or dysregulation of the D2 receptor system (Dodd, 2007).

The link between RLS and Parkinson's disease (PD) further illuminates the role of dopamine. While RLS is more prevalent in PD patients than in the general population, it is important to note that RLS does not predispose individuals to developing PD (Inoue, 2009; Massey & Robertson, 2020; Jankovic, 2008). However, late-onset, frequent, and asymmetrical RLS symptoms may precede the onset of motor symptoms of PD in some individuals, suggesting a shared dopaminergic pathology in a subset of patients (Suzuki et al., 2019; Leszek, 2021; Friedman & Fernandez, 2000). The pathology in PD involves profound degeneration of dopaminergic neurons in the substantia nigra, a key component of the basal ganglia (Mizuno, 1997; Jankovic, 2008). In contrast, the dopaminergic abnormality in RLS is thought to be a functional deficit rather than a result of widespread neurodegeneration, potentially explaining why RLS symptoms respond to much lower doses of dopaminergic agents than are required in PD (Raux et al., 2010).

The circadian nature of RLS symptoms also points to a dopaminergic mechanism. Dopamine levels in the central nervous system naturally decline in the evening and at night, which corresponds with the period of symptom exacerbation in RLS patients (Bogan, 2006; Walters & Zee, 2023). This suggests that RLS patients may have a reduced capacity to compensate for this physiological nocturnal dip in dopamine function, leading to the emergence of symptoms (Pinder, 2006).

#### Brain Iron Metabolism

A second major pillar of RLS pathophysiology is disordered brain iron metabolism (Pinder, 2006; Massey & Robertson, 2020; Hamdan & Machin, 2009). The connection between iron and RLS is robust, supported by the observation that iron deficiency is a common cause of secondary RLS and that symptoms are often relieved by iron supplementation, particularly when serum ferritin levels are low (Inoue, 2009; Pinder, 2006; Smith, 2009). The association is so strong that iron therapy is recommended whenever serum ferritin levels are low in RLS patients (Pinder, 2006; Raux et al., 2010).

The link between iron and dopamine systems is direct and mechanistically crucial. Iron is an essential cofactor for tyrosine hydroxylase, the rate-limiting enzyme in the synthesis of dopamine (Raux et al., 2010; Medcalf & Bhatia, 2006). Therefore, a deficiency in brain iron could lead to impaired dopamine production, directly contributing to the dopaminergic dysfunction seen in RLS (Hamdan & Machin, 2009). Neuropathological and neuroimaging studies have provided physical evidence for this link. Magnetic resonance imaging (MRI) has demonstrated reduced iron concentrations in specific brain regions of RLS patients, notably the substantia nigra and putamen, which are key areas of the dopaminergic system (Medcalf & Bhatia, 2006). Furthermore, cerebrospinal fluid (CSF) studies in primary RLS patients have revealed low ferritin levels, indicating deficient iron stores within the central nervous system, which correlates with symptom severity (Medcalf & Bhatia, 2006; Raux et al., 2010).

The problem in RLS may not be a simple systemic iron deficiency but rather a disruption in the mechanisms that transport and regulate iron within the brain (Allen, 2006). This could explain why some patients with RLS have normal peripheral iron stores but still benefit from iron therapy, and why brain iron levels can be low even with normal serum iron (Pinder, 2006). The interaction is complex; for instance, some proton pump inhibitors (PPIs) may interfere with iron absorption, potentially leading to iron deficiency and the development of RLS-like symptoms in a subpopulation of patients (Smith, 2009).

#### Other Implicated Neurotransmitter and Ion Channel Systems

While the dopamine and iron hypotheses are central, they do not fully explain all features of RLS, such as the prominent sensory symptoms. This suggests the involvement of other neurobiological systems.

**Opioid System:** The efficacy of opioids in treating RLS symptoms points to an involvement of the endogenous opioid system (Pinder, 2006; Perkins et al., 2010; Hamilton-Stubbs & Walters, 2011). Opioids are potent modulators of pain and sensory pathways within the central nervous system (Mao, 2017). Their effectiveness in RLS suggests that these pathways may be dysregulated, contributing to the unpleasant dysesthesias that characterize the disorder. The relief provided by opioids might occur through modulation of descending pain pathways or through interactions with dopaminergic systems in the basal ganglia (Friedman & Fernandez, 2000).

**Glutamate and GABA Systems:** The therapeutic utility of α2δ ligands, such as gabapentin and pregabalin, suggests a role for neuronal hyperexcitability in RLS pathophysiology (Perkins et al., 2010; Massey & Robertson, 2020; Sławek, 2018). These drugs bind to the α2δ subunit of voltage-gated calcium channels, modulating neurotransmitter release, particularly of excitatory transmitters like glutamate (Cvijanović et al., 2011). By reducing neuronal hyperexcitability in sensory pathways, these agents may dampen the generation or transmission of the abnormal sensations in RLS (Jensen, 2002). Conversely, the gamma-aminobutyric acid (GABA) system, the main inhibitory system in the brain, may also be involved. Some treatments, like benzodiazepines (e.g., clonazepam), enhance GABAergic inhibition and can be effective for RLS, possibly by reducing overall neuronal excitability and promoting sleep (Pinder, 2006; Perkins et al., 2010; Ryan & Slevin, 2007).

**Serotonergic System:** The serotonergic system appears to have a modulatory, and often exacerbating, role in RLS. A common clinical observation is the worsening of RLS symptoms with the use of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which are widely prescribed antidepressants (During & Winkelman, 2022; Tavares et al., 2017; Rubí, 2018). The mechanism is thought to involve the inhibitory effect of serotonin on dopaminergic neurons, particularly in the spinal cord and basal ganglia (Dodd, 2007). By increasing serotonergic tone, these medications may further suppress an already compromised dopaminergic system, thereby unmasking or worsening RLS symptoms (During & Winkelman, 2022; Ostroumova et al., 2020).

#### Peripheral Nervous System Contributions

While RLS is primarily considered a central nervous system disorder, there is substantial evidence for contributions from the peripheral nervous system (Hong, 2008; Massey & Robertson, 2020). RLS is frequently secondary to conditions involving peripheral nerve damage, such as peripheral neuropathy and lumbosacral radiculopathy (İpekdal et al., 2011; Medcalf & Bhatia, 2006; Hong, 2008). Patients with neuropathy often complain of RLS-like symptoms, including paresthesias and an urge to move, suggesting that abnormal afferent signals from damaged peripheral nerves could trigger or contribute to the central RLS generator (Hong, 2008; Mendell & Sahenk, 2003).

Small fiber neuropathy, in particular, can trigger RLS or mimic its symptoms (Inoue, 2009). These small nerve fibers are involved in transmitting pain and temperature sensations, and their dysfunction could directly lead to the burning, tingling, and painful sensations reported by many RLS patients (Mendell & Sahenk, 2003; Al et al., 2012). In some cases, trauma to a limb has been associated with the onset of strictly unilateral RLS, suggesting that a peripheral injury can, in some instances, initiate the central processes underlying the syndrome (LeWitt, 2018). This suggests a model where peripheral nerve hyperexcitability or abnormal sensory input serves as a trigger that activates a predisposed and dysfunctional central sensory-motor network (Jensen, 2002; Coggan et al., 2011).

### Genetic and Molecular Basis

The familial nature of Restless Legs Syndrome provides strong evidence for a significant genetic contribution to its etiology (Pinder, 2006; Massey & Robertson, 2020). A positive family history is considered a supportive clinical feature for diagnosis and is reported in approximately 40-50% of cases, and in some studies up to 92% (Provini et al., 2008; Walters et al., 1995; Sitaru et al., 1999; Medcalf & Bhatia, 2006). This is particularly true for primary or idiopathic RLS, especially the early-onset form (symptoms beginning before age 30-45), which is frequently familial (İpekdal et al., 2011; Inoue, 2009; Medcalf & Bhatia, 2006).

The mode of inheritance in these familial cases often appears to be autosomal dominant with variable penetrance and clinical expressivity (Walters et al., 1995; Ulfberg et al., 1999; Medcalf & Bhatia, 2006; Bachmann, 2015). This means that an individual needs to inherit only one copy of the mutated gene from one parent to be at risk of developing the disorder, but not everyone who inherits the gene will manifest symptoms, and the severity can vary widely among affected family members (Walters et al., 1995). The high heritability of RLS has been confirmed in studies of monozygotic twins, who show a concordance rate of 83% (Raux et al., 2010).

While the provided literature does not specify the exact genes, it consistently notes that genetic research has successfully demonstrated linkage to several chromosomal loci (Pinder, 2006; Raux et al., 2010). More recent genome-wide association studies have identified associations with variants in four specific genes that play roles in fetal limb development and axonal guidance (Raux et al., 2010). This finding is particularly intriguing as it may provide a molecular link to the sensorimotor nature of the disorder. One of these identified genes, BTBD9, has been found to correlate with serum ferritin levels and the presence of periodic limb movements during sleep, directly connecting a genetic risk factor to the two core pathophysiological pillars of RLS: iron metabolism and motor manifestations (Raux et al., 2010).

The genetic basis appears to differ between the two primary phenotypes of RLS. The early-onset form, which typically begins before age 45, is more strongly associated with a positive family history and is considered the primary genetic form of the disorder (Inoue, 2009; Medcalf & Bhatia, 2006). In contrast, the late-onset form is more often sporadic and is more frequently associated with secondary causes, such as iron deficiency or other medical conditions (Inoue, 2009). This suggests a model where a strong genetic predisposition leads to an early manifestation of the disease, while in later-onset cases, a weaker genetic susceptibility may require additional environmental or medical triggers to unmask the syndrome (Massey & Robertson, 2020).

At the molecular level, the leading hypotheses converge on pathways related to dopamine signaling and iron homeostasis, which are likely influenced by these genetic factors (Hamdan & Machin, 2009). The genetic variants identified may affect the expression or function of proteins involved in dopamine synthesis, receptor function, or the intricate cellular machinery that regulates iron uptake, storage, and transport within the central nervous system (Raux et al., 2010; Pinder, 2006). For example, a genetic defect could impair the function of iron-management proteins in the substantia nigra, leading to the localized iron deficiency observed in neuropathological studies of RLS brains (Raux et al., 2010). This localized iron deficit would then disrupt the function of iron-dependent enzymes like tyrosine hydroxylase, leading to insufficient dopamine production and the subsequent sensorimotor symptoms (Medcalf & Bhatia, 2006). The complexity and heterogeneity of RLS suggest that it is likely a polygenic disorder, where multiple genes with small individual effects interact with each other and with environmental factors to determine an individual's overall risk and clinical presentation (Williams, 2011).

### Brain Structure and Function

While RLS is primarily defined by its subjective symptoms, advances in neuroimaging and neurophysiology have begun to reveal objective structural and functional abnormalities within the central nervous system. These findings provide critical support for the biological underpinnings of the disorder and help to localize the dysfunction to specific neural circuits, primarily involving the subcortical motor system.

#### Neuroimaging Findings

Structural and functional neuroimaging studies have been instrumental in bridging the gap between the leading neurochemical hypotheses and the underlying neuroanatomy of RLS. One of the most consistent findings comes from magnetic resonance imaging (MRI) studies examining brain iron content. These studies have demonstrated a reduction of iron in specific areas of the brain, most notably the substantia nigra and the putamen, which are key nuclei of the basal ganglia (Medcalf & Bhatia, 2006). This finding is highly significant as it provides a direct anatomical correlate for the brain iron deficiency hypothesis and links it to the dopaminergic system, which is densely concentrated in these regions (Jankovic, 2008). The reduction in iron is reported to be proportionate to the severity of RLS symptoms, strengthening the causal link (Medcalf & Bhatia, 2006).

Functional neuroimaging, particularly Positron Emission Tomography (PET), has further elucidated the nature of the dopaminergic dysfunction. PET studies in RLS patients have revealed mildly reduced uptake of 18F-dopa in the striatum, along with a significant reduction in D2 dopamine receptor binding (Medcalf & Bhatia, 2006). Reduced D2 receptor binding suggests a post-synaptic dopaminergic deficit, which could impair the ability of striatal neurons to respond to dopamine signals (Medcalf & Bhatia, 2006). This aligns with the understanding of basal ganglia circuitry, where D2 receptors play a crucial role in the "indirect pathway" that modulates motor output (Nambu, 2012; Dodd, 2007).

It is important to note that, unlike in Parkinson's disease where structural imaging can show degeneration of the substantia nigra, standard clinical brain MRI is typically normal in patients with primary RLS (Mizuno, 1997; Sitaru et al., 1999). The abnormalities are subtle and require specialized imaging techniques to detect, reinforcing the concept that RLS is a disorder of brain *function* rather than gross structural damage (Mano & Thomas, 2018).

#### Neural Circuits and Functional Connectivity

The constellation of sensory, motor, and circadian symptoms in RLS, combined with the neuroimaging findings, strongly suggests that RLS is a neural network disorder (Mano & Thomas, 2018). The dysfunction is not confined to a single brain region but rather involves a distributed network of interconnected structures.

The central hub of this dysfunctional network appears to be the basal ganglia and their connections within the cortico-striatal-thalamocortical loops (Nambu, 2012; Pillon et al., 1996). These circuits are fundamental for motor control, planning, and the integration of sensory information to guide movement (Barton et al., 2009). Dopaminergic neurons originating in the substantia nigra provide critical modulation to these loops. A functional deficiency in this dopaminergic input, as suggested by PET and iron studies, would disrupt the delicate balance between the direct (pro-kinetic) and indirect (anti-kinetic) pathways of the basal ganglia (Nambu, 2012). This imbalance could lead to inappropriate motor output signals, potentially manifesting as the urge to move and the involuntary periodic limb movements (PLMs) seen in RLS (Pillon et al., 1996; Friedman & Fernandez, 2000).

The profound sensory component of RLS implies that the network dysfunction extends to somatosensory processing pathways. The thalamus, a key relay station for sensory information to the cortex, is heavily implicated (Dodd, 2007). Abnormal processing of sensory information within the thalamus, potentially due to dysregulated dopaminergic or other neurotransmitter input, could lead to the generation or amplification of the dysesthesias (Dejerine & Roussy, 1969). The fact that symptoms are often described as deep-seated in the muscles or bones rather than on the skin suggests involvement of pathways processing proprioceptive and deep somatic sensation (Garcı́a-Borreguero et al., 2004).

Furthermore, the distinct circadian rhythm of RLS symptoms points to a role for the brain's master clock in the suprachiasmatic nucleus of the hypothalamus and its connections to arousal and motor centers in the brainstem (Walters & Zee, 2023; Reid & Zee, 2004). These brainstem centers, including the locus coeruleus and raphe nuclei, utilize norepinephrine and serotonin, respectively, and have extensive projections that modulate spinal cord activity and arousal state (Dodd, 2007). A disruption in the normal circadian modulation of these systems, interacting with the nocturnal dip in dopamine, could create a state of spinal cord hyperexcitability specifically in the evening and night, facilitating the emergence of both the sensory and motor symptoms of RLS (Walters & Zee, 2023). Neurophysiological studies have supported this concept, indicating changes in the excitability of spinal reflexes and cortical motor pathways in RLS patients, suggesting a state of central nervous system disinhibition (Medcalf & Bhatia, 2006).

### Developmental Neurobiology

Restless Legs Syndrome can manifest at any point across the lifespan, from childhood to old age, but its clinical presentation and likely underlying mechanisms can differ depending on the age of onset (Mansur et al., 2019; Medcalf & Bhatia, 2006; Ulfberg et al., 1999). The disorder is broadly categorized into two primary phenotypes: an early-onset form and a late-onset form, which appear to have distinct developmental and etiological profiles (Inoue, 2009).

#### Early-Onset Restless Legs Syndrome

The early-onset form of RLS, typically defined by symptom onset before the age of 30 or 45, is strongly associated with a genetic predisposition (İpekdal et al., 2011; Inoue, 2009; Medcalf & Bhatia, 2006). In these cases, a positive family history is common, and the inheritance pattern often suggests an autosomal dominant mode of transmission (Medcalf & Bhatia, 2006; Bachmann, 2015). The clinical course of early-onset RLS is generally characterized by a slow, insidious progression of symptoms over many years or decades (Medcalf & Bhatia, 2006). Patients may experience long periods of remission, with symptoms waxing and waning over time (Ulfberg et al., 1999).

Although RLS is often considered a disorder of middle or older age, a significant proportion of patients report that their symptoms began in childhood or adolescence (Medcalf & Bhatia, 2006; Mansur et al., 2019). However, the diagnosis is frequently delayed, often until the third decade of life or later, because the symptoms in young people may be misinterpreted or dismissed (Mansur et al., 2019; Medcalf & Bhatia, 2006). For example, the leg discomfort and restlessness in children may be mislabeled as "growing pains" (Medcalf & Bhatia, 2006). Children may also present with behavioral manifestations, such as hyperactivity or inattention at school, which are secondary to the chronic sleep disruption caused by RLS, leading to potential misdiagnosis of attention-deficit/hyperactivity disorder (ADHD) (Pinder, 2006). The developing nervous system in childhood may process and express the underlying neurobiological dysfunction of RLS differently than in adults, contributing to this diagnostic challenge (Nomura, 1997).

#### Late-Onset Restless Legs Syndrome

In contrast, the late-onset form of RLS (onset after age 45) is more frequently sporadic, with a less robust link to family history (Medcalf & Bhatia, 2006). This phenotype is more commonly associated with secondary causes, such as iron deficiency, end-stage renal disease, pregnancy, diabetes, and peripheral neuropathy (Inoue, 2009; Medcalf & Bhatia, 2006; Klepitskaya, 2016). The clinical course of late-onset RLS tends to be more rapid and progressive compared to the early-onset form (Medcalf & Bhatia, 2006).

This distinction suggests different developmental pathways to the same clinical syndrome. In early-onset RLS, a strong genetic vulnerability may be sufficient to cause symptoms, possibly due to a congenital or developmental abnormality in dopamine or iron metabolic pathways (İpekdal et al., 2011). In late-onset RLS, a weaker genetic predisposition may require the accumulation of age-related changes or the presence of an acquired medical condition to trigger the clinical expression of the disorder (Massey & Robertson, 2020). Age-related declines in the dopaminergic system and changes in iron metabolism, which are part of the normal aging process, may lower the threshold for symptom development in susceptible individuals (Schiffter, 1988; Pinder, 2006).

Pregnancy represents a unique developmental period associated with a high incidence of secondary RLS (Klepitskaya, 2016; O'Keeffe, 1996; Massey & Robertson, 2020). Hormonal fluctuations, changes in iron and folate metabolism, and mechanical factors during pregnancy are thought to contribute to the temporary development of RLS symptoms, which typically resolve after delivery (Klepitskaya, 2016; Medcalf & Bhatia, 2006). This highlights how significant physiological changes during different life stages can interact with an underlying predisposition to modulate the expression of RLS.

### Treatment Mechanisms

The management of Restless Legs Syndrome is primarily symptomatic, aimed at alleviating the distressing sensorimotor complaints and improving sleep quality (Paulson, 2000; Sławek, 2018). The mechanisms of action of the most effective pharmacological treatments provide further convergent evidence for the core neurobiological hypotheses of the disorder, particularly the central roles of dopamine and iron.

#### Dopaminergic Therapies

Dopaminergic agents, including the dopamine precursor levodopa and direct dopamine receptor agonists (e.g., pramipexole, ropinirole, rotigotine), are the first-line treatment for moderate to severe daily RLS (Pinder, 2006; Sławek, 2018; Perkins et al., 2010). These drugs act by directly supplementing or mimicking the action of dopamine in the central nervous system, thereby compensating for the underlying dopaminergic dysfunction (Ryan & Slevin, 2007; Hamilton-Stubbs & Walters, 2011). Levodopa provides a substrate for dopamine synthesis, while dopamine agonists directly stimulate postsynaptic dopamine receptors, particularly D2 and D3 receptors, in the striatum and other relevant brain regions (Medcalf & Bhatia, 2006; Dodd, 2007). Their effectiveness, especially in alleviating symptoms during the evening and night, supports the hypothesis that RLS arises from a failure to manage the natural nocturnal decline in central dopamine activity (Bogan, 2006).

A critical aspect of long-term dopaminergic treatment is the phenomenon of augmentation, a paradoxical iatrogenic worsening of RLS symptoms (Medcalf & Bhatia, 2006; Massey & Robertson, 2020). Augmentation is characterized by an earlier onset of symptoms during the day, a shorter latency to symptom onset at rest, increased symptom intensity, and often a spread of symptoms to previously unaffected body parts, such as the arms (Lim et al., 2015; Medcalf & Bhatia, 2006). This phenomenon is thought to represent a form of neuroplasticity, where chronic stimulation of dopamine receptors leads to maladaptive changes in the dopaminergic system, potentially including receptor downregulation or sensitization (Lim et al., 2015). Augmentation is more common with shorter-acting agents like levodopa and less so with longer-acting dopamine agonists, though it remains a significant clinical challenge (Medcalf & Bhatia, 2006; Conti, 2009). Its existence underscores the complexity of dopamine dysregulation in RLS, suggesting that simple dopamine replacement is not a complete solution and that the precise nature of the dopaminergic deficit is more nuanced than a simple deficiency.

#### Iron Supplementation

For patients with evidence of iron deficiency, particularly a serum ferritin level below 45-50 µg/L, iron supplementation is a fundamental treatment strategy (Pinder, 2006; Raux et al., 2010; Massey & Robertson, 2020). The mechanism is straightforward: restoring systemic iron stores is intended to increase the availability of iron to the central nervous system (Allen, 2006). By providing an adequate supply of this crucial cofactor for tyrosine hydroxylase, iron therapy aims to normalize the rate of dopamine synthesis in the brain, thereby addressing the root cause of the dopaminergic deficit (Medcalf & Bhatia, 2006; Raux et al., 2010). The clinical improvement seen with iron therapy provides strong support for the brain iron deficiency hypothesis as a key upstream event in RLS pathogenesis (Pinder, 2006).

#### Alpha-2-Delta Ligands

Anticonvulsant drugs that are α2δ ligands, such as gabapentin and pregabalin, are increasingly used as first-line or second-line treatments, particularly for patients with painful RLS symptoms or those who cannot tolerate or have developed augmentation on dopaminergic agents (Perkins et al., 2010; Sławek, 2018; Massey & Robertson, 2020). These agents are not believed to act directly on the dopamine system. Instead, their mechanism involves binding to the α2δ subunit of voltage-gated calcium channels on presynaptic neurons (Cvijanović et al., 2011). This action reduces the influx of calcium, which in turn decreases the release of several excitatory neurotransmitters, including glutamate, in hyperexcited neural circuits (Cvijanović et al., 2011). In the context of RLS, this is thought to dampen the hyperexcitability within central sensory pathways (e.g., in the spinal cord and thalamus) that may be responsible for generating the unpleasant dysesthesias (Jensen, 2002; Perkins et al., 2010). Their efficacy highlights the role of generalized neuronal hyperexcitability as a downstream consequence of the primary dopaminergic and iron-related deficits.

#### Other Pharmacological Approaches

Opioids are effective for severe, refractory RLS, though their use is limited by concerns about tolerance and dependence (Pinder, 2006; Perkins et al., 2010). They act on opioid receptors within central pain-modulating circuits, including the periaqueductal gray, thalamus, and spinal cord, to reduce the perception of unpleasant or painful sensations (Mao, 2017). Their effectiveness suggests an overlap between the neural circuits processing RLS sensations and those processing pain (Ford & Pfeiffer, 2007).

Benzodiazepines, such as clonazepam, are sometimes used, though their primary benefit may be related to improving sleep continuity rather than treating the core sensorimotor symptoms of RLS (Perkins et al., 2010; Ryan & Slevin, 2007). By enhancing GABAergic inhibition, they can reduce the number of arousals associated with PLMS and promote sleep, though they do not typically reduce the frequency of the movements themselves (Pinder, 2006).

### Future Directions

Despite significant progress in understanding the biological basis of Restless Legs Syndrome, several critical questions remain unanswered, pointing the way for future research. The current framework, centered on dopamine and iron dysregulation, provides a robust foundation, but a more complete and nuanced picture of the disorder's pathophysiology is needed to develop more effective and durable treatments.

One of the most pressing challenges is to move beyond symptomatic therapies toward disease-modifying or curative interventions. A key aspect of this will be a deeper investigation into the genetic underpinnings of RLS. While genome-wide association studies have identified several risk loci, the specific causative genes and the molecular mechanisms by which they contribute to the RLS phenotype are still largely unknown (Williams, 2011; Raux et al., 2010). Future genetic studies should aim to identify rare variants with larger effect sizes and to elucidate how genetic risk factors interact with environmental triggers and comorbidities to influence disease expression and severity. Understanding these pathways could reveal novel targets for therapeutic development.

The phenomenon of augmentation remains a major limitation of long-term dopaminergic therapy and a critical area for future study (Medcalf & Bhatia, 2006; Massey & Robertson, 2020). The neuroplastic changes that underlie this iatrogenic worsening of symptoms are poorly understood. Advanced neuroimaging and neurophysiological techniques could be employed to longitudinally track changes in dopamine receptor density, transporter function, and neural circuit connectivity in patients undergoing dopaminergic treatment. This could help identify biomarkers that predict the risk of augmentation and lead to the development of strategies to prevent or reverse it, perhaps by exploring alternative, non-dopaminergic pathways or novel drug delivery systems that provide more physiological dopamine stimulation.

The precise nature and extent of the neural network dysfunction in RLS also warrants further exploration (Mano & Thomas, 2018). While the basal ganglia are clearly implicated, the roles of the cerebellum, brainstem, spinal cord, and various cortical regions in generating the complex sensorimotor and circadian symptoms need to be more clearly defined. Functional connectivity studies using fMRI could map the dynamic interactions between these regions at different times of day and in response to rest and movement. Such studies could help clarify how peripheral sensory inputs from conditions like neuropathy interact with central networks to trigger symptoms (Hong, 2008).

Furthermore, the strong circadian component of RLS presents a unique avenue for investigation and potential intervention. As suggested by recent reviews, studies should be conducted to determine if the signs and symptoms of RLS can be phase-shifted by circadian-modulating stimuli, such as bright light therapy, in concert with established circadian markers like melatonin (Walters & Zee, 2023). This could not only provide definitive proof of the endogenous circadian rhythmicity of RLS but also open the door to non-pharmacological, chronotherapeutic approaches to management (Reid & Zee, 2004).

Finally, the development of objective, quantifiable biomarkers for RLS diagnosis and severity remains a crucial goal. Current diagnosis relies on subjective patient reports, which can be challenging, especially in children or individuals with cognitive impairment (Summerton, 2004; Walters et al., 1995). While polysomnography can quantify PLMS and actigraphy can measure motor restlessness, these are not specific to RLS (Inoue, 2009; Istre, 2002). Future research could focus on identifying specific neurophysiological signatures (e.g., from EEG or spinal reflex studies) or biochemical markers (e.g., in CSF or blood) that are unique to RLS, which would revolutionize diagnostic accuracy and facilitate more objective clinical trials.

### Conclusion

Restless Legs Syndrome is a complex and often distressing neurological condition that arises from a confluence of genetic predispositions and acquired physiological stressors, manifesting as a profound sensorimotor disturbance with a distinct circadian rhythm. The biological and neurological basis of RLS, while not yet fully elucidated, is increasingly understood as a network disorder of the central nervous system (Mano & Thomas, 2018). The core of this dysfunction lies in the intricate relationship between central dopaminergic pathways and brain iron homeostasis (Pinder, 2006; Massey & Robertson, 2020). Evidence strongly indicates that a functional deficit in dopaminergic signaling, particularly within subcortical circuits involving the basal ganglia, is a primary driver of the motor urge (Medcalf & Bhatia, 2006). This dopaminergic dysregulation appears to be closely linked to, and likely caused by, a state of localized brain iron deficiency, which impairs the synthesis of dopamine (Raux et al., 2010; Hamdan & Machin, 2009).

The pathophysiology, however, extends beyond this central dyad. The involvement of other neurotransmitter systems, including opioids, glutamate, and serotonin, highlights the widespread nature of the neural dysregulation and helps to explain the prominent sensory dysesthesias and the modulatory effects of various medications (Perkins et al., 2010; During & Winkelman, 2022). Furthermore, the frequent association of RLS with peripheral nervous system disorders, such as neuropathy, underscores the importance of afferent sensory input in triggering or exacerbating the central generator of symptoms (Hong, 2008).

The strong heritability of early-onset RLS points to a significant genetic foundation, suggesting that certain individuals possess an intrinsic vulnerability within these neurobiological systems (Williams, 2011; Walters et al., 1995). In contrast, late-onset RLS often appears to require an additional insult, such as a medical comorbidity or environmental factor, to become clinically manifest (Inoue, 2009). This dual-pathway model emphasizes the multifactorial etiology of the syndrome.

The mechanisms of current treatments, from dopaminergic agonists to iron supplementation and α2δ ligands, further validate our understanding of the underlying biology. However, the challenge of treatment-related complications like augmentation serves as a stark reminder of the complexities of these systems and the need for more sophisticated therapeutic strategies (Medcalf & Bhatia, 2006). In synthesizing the available evidence, it becomes clear that RLS is not merely a disorder of sleep, movement, or sensation, but an integrated disruption of all three. Future research focused on genetics, neuroplasticity, and circadian biology will be essential to unravel the remaining mysteries of this common but still enigmatic condition and to improve the lives of the millions who suffer from it.

## References

1. Abay, H., & Kaplan, S. (2019). Current Approaches in Premenstrual Syndrome Management. Bezmialem Science. https://doi.org/10.14235/bas.galenos.2018.2358
2. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
3. Aghababaeian, H., & Ahvazi, L. A. (2018). Isn’t it Time to Use Opioid Drugs in Emergency Medical Services?. DOAJ (DOAJ: Directory of Open Access Journals).
4. Ahemad, M., Ahmad, P. M. F., & Shafaat, M. (2018). Effect of Dalak (Massage) in the Management of Sahar (Insomnia). https://doi.org/10.37591/rrjoush.v5i2.130
5. Al, I., Ammar, A., & Al, M. (2012). Pathophysiology of Paresthesia. InTech eBooks. https://doi.org/10.5772/33172
6. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
7. Ali, N., Rasheed, A., Tariq, I., Abdullah, F., Sarwar, A., Atta, R., & Qammer, Z. (2018). Adjunct Use of Low Dose Risperidone Verses Adjunct Use of Clonazepam with an SSRI in Treatment of Moderate to Severe Anxiety States; A Comparative Study. National Journal of Health Sciences. https://doi.org/10.21089/njhs.32.0051
8. Allen, R. E., & Kirby, K. A. (2012). Nocturnal leg cramps.. PubMed.
9. Allen, R. P. (2006). Restless Legs Syndrome and Periodic Limb Movement Disorder: Nightwalkers. CRC Press eBooks. https://doi.org/10.3109/9780849374494-6
10. Allen, R. P. (2012). Restless Legs Syndrome (Willis-Ekbom Disease) and Periodic Limb Movements. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195376203.013.0034
11. Alnafesah, N. A., Alshamrani, F. D., Grain, A. Z. B., Alshehre, D. H. D., Alanazi, N. M., Alalyan, A. A., Shaheen, H. S. B., & Altheyab, S. A. (2022). A survey Based Analysis of Low Back Pain and Best Practice Care. International Journal of Pharmaceutical and Bio-Medical Science. https://doi.org/10.47191/ijpbms/v2-i12-01
12. Alvarenga, P. G. D., Hounie, A. G., Mercadante, M. T., Miguel, E. C., & Rosário, M. C. D. (2007). Obsessive-compulsive disorder: A historical overview.. https://doi.org/10.4324/9780203936870-7
13. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
14. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
15. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
16. andrew, A., Seng, Boon, Chua, Pwn, Keeling, Tg, & Dinan (2006). Role of cholecystokinin and central serotonergic receptors in functional dyspepsia. 世界胃肠病学杂志：英文版（电子版）.
17. Angelini, P. (2008). Tako Tsubo, where everything can be variable: or can it? The quest for solid grounds in a slippery entity. EP Europace. https://doi.org/10.1093/europace/eun268
18. Arnd‐Caddigan, M. (2006). Somatoform Disorders and a History of Abuse. Journal of Social Work. https://doi.org/10.1177/1468017306062221
19. Arroyo, H., Klipstein, K., Ernst, C. L., & Finkel, J. H. (2016). Somatic Symptom and Related Disorders, Including Illness Anxiety, Factitious, Malingering, and Conversion Disorders. https://doi.org/10.1002/9781118654231.ch20
20. Bachmann, C. (2015). Padma 28 bei Restless-Legs-Syndrom: Fallberichte wecken Hoffnungen auf Wirksamkeit. Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine. https://doi.org/10.1159/000434622
21. Baguma, M., & Ossemann, M. (2017). Paroxysmal Kinesigenic Dyskinesia as the Presenting and Only Manifestation of Multiple Sclerosis after Eighteen Months of Follow-Up. Journal of Movement Disorders. https://doi.org/10.14802/jmd.16055
22. Balasubramaniam, R. (2018). The enigma of central sensitivity syndrome in dentistry. Journal of Indian Academy of Oral Medicine and Radiology. https://doi.org/10.4103/jiaomr.jiaomr_148_18
23. Baldwin, E. L., Sarver, M. M., Jaykel, M., Foster, N., & Erickson, M. (2020). Acute exertional compartment syndrome of the lumbar paraspinal muscles in a weightlifter. A case report. North American Spine Society Journal (NASSJ). https://doi.org/10.1016/j.xnsj.2020.100033
24. Baloh, R. W., Honrubia, V., & Kerber, K. A. (2011). The History of the Dizzy Patient. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195387834.003.0005
25. Barton, B., Zauber, S. E., & Goetz, C. G. (2009). Movement Disorders Caused by Medical Disease. Seminars in Neurology. https://doi.org/10.1055/s-0029-1213731
26. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
27. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
28. Bell, C. M. (2009). R. https://doi.org/10.1093/oso/9780195341591.003.0018
29. Bellini, M. (2006). Gastrointestinal manifestations in myotonic muscular dystrophy. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v12.i12.1821
30. Beneš, H., Walters, A. S., Allen, R. P., Hening, W. A., & Kohnen, R. (2007). Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Movement Disorders. https://doi.org/10.1002/mds.21604
31. Bentley, A. (2006). 'Im not sleeping well.' : main article. CME: Your SA Journal of CPD.
32. Berkowitz, D., Naveh, Y., & Berant, M. (1997). “Infantile Colic” as the Sole Manifestation of Gastroesophageal Reflux. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/00005176-199702000-00022
33. Berlot, R., Rothwell, J. C., Bhatia, K. P., & Kojović, M. (2020). Variability of Movement Disorders: The Influence of Sensation, Action, Cognition, and Emotions. Movement Disorders. https://doi.org/10.1002/mds.28415
34. Berra, K., Fletcher, B. J., & Miller, N. H. (2008). Chronic stable angina: Addressing the needs of patients through risk reduction, education and support. Clinical and investigative medicine. https://doi.org/10.25011/cim.v31i6.4927
35. Bezerra, E. D. L., & Zimmermann, M. (2015). DISTÚRBIOS COMPORTAMENTAIS EM CÃES: Ansiedade por Separação.
36. Bibbo, C., Lin, S. S., & Cunningham, F. J. (2000). Acute traumatic compartment syndrome of the foot in children. Pediatric Emergency Care. https://doi.org/10.1097/00006565-200008000-00007
37. Binkofski, F., & Reetz, K. (2008). Apraxia. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198569275.003.0006
38. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
39. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
40. Bleeker, M. L., & Amr, S. (1999). Clinical Update: Strength Testing–Grip and Pinch. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.1999.mayjun06
41. Boeft, M. D., Dessel, N. C.-V., & Wouden, J. C. V. D. (2017). How should we manage adults with persistent unexplained physical symptoms?. BMJ. https://doi.org/10.1136/bmj.j268
42. Bogan, R. (2006). Effects of restless legs syndrome (RLS) on sleep. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/nedt.2006.2.4.513
43. Bollen, E., Sanders, E. A. C. M., & Velde, E. A. V. D. (2009). Presenting signs and symptoms in multiple sclerosis. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1986.tb03274.x
44. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
45. Bonnet, M. H., & Arand, D. L. (2008). Chronic insomnia. CRC Press eBooks. https://doi.org/10.3109/9780203091715-12
46. Boretto, J. G., Rellán, I., & Cicco, F. L. D. (2022). Compression Neuropathy. CRC Press eBooks. https://doi.org/10.1201/9781003125938-15
47. Borge, A. I. H., & Nordhagen, R. (2002). [Recurrent pain in children and parents--no factual evidence of familial pain clustering].. PubMed.
48. Bos, J., Leeuwen, R. B. V., & Bruintjes, T. D. (2018). [Motion sickness in motion: from carsickness to cybersickness].. PubMed.
49. Bradic, L., Lokmić-Pekić, I., & Dzevad, B. (2018). Psychiatric comorbidity in patients with posttraumatic stress disorder and enduring personality change after catastrophic experience. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c22b
50. Bravo, K. G. B., Andrade, J. E. L., Álava, V. K. L., & Cruz, A. N. M. (2019). Anestesiología: manejo invasivo del dolor agudo y crónico. RECIMUNDO. https://doi.org/10.26820/recimundo/3.(3).septiembre.2019.1463-1480
51. Brentar, J. (2008). Psychological Disorders and Functional Limitations.. Learning Disabilities: a Multidisciplinary Journal.
52. Brignole, M. (2006). Neurally mediated syncope. CRC Press eBooks. https://doi.org/10.1201/b13301-22
53. Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., Dijk, J. G. V., Fitzpatrick, A., Hohnloser, S. H., Janousek, J., Kapoor, W. N., Kenny, R. A., Kułakowski, P., Masotti, G., Moyá, A., Raviele, A., Sutton, R., Theodorakis, G., Ungar, A., & Wieling, W. (2004). Guidelines on Management (diagnosis and treatment) of syncope ? update 2004. EP Europace. https://doi.org/10.1016/j.eupc.2004.08.008
54. Brodsky, M., & Hansen, A. (2017). Pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190466268.003.0012
55. Bronstein, A. M. (2018). Evaluation of Balance. CRC Press eBooks. https://doi.org/10.1201/9780203731017-62
56. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
57. Brousseau, M., Mayer, P., & Lavigne, G. (2003). Physiologie et manipulations expérimentales des interrelations entre la douleur et le sommeil. Douleur et Analgésie. https://doi.org/10.1007/bf03007107
58. Brown, C. W., & Gorup, J. M. (1997). Return to Noncontact Sports After Spinal Injury. Sports Medicine and Arthroscopy Review. https://doi.org/10.1097/00132585-199710000-00009
59. BS, A. H., & BA, M. F. (2018). Glossary. https://doi.org/10.1002/9781119449737.gloss
60. BSc, P. L. G. R., & BSc, D. B. R. (2008). Glossary of Technical Terms. https://doi.org/10.1002/9781444302264.gloss
61. Bujosa, C. M., & Monsalve, M. H. (2007). Caso Clínico "La esquizofrenia de inicio senil o cuando el reto de saber pseudodiagnosticar". Norte de Salud mental.
62. Butera, K. A., Roff, S., Buford, T. W., & Cruz‐Almeida, Y. (2019). &lt;p&gt;The impact of multisite pain on functional outcomes in older adults: biopsychosocial considerations&lt;/p&gt;. Journal of Pain Research. https://doi.org/10.2147/jpr.s192755
63. Calle-Cruz, L. F. (2021). Primary health care services with diagnosis of tumor asthenia. International Journal of School and Cognitive Psychology.
64. Campea, S., & Haselkorn, J. K. (2016). Disorders of Mobility in Multiple Sclerosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199341016.003.0014
65. Campos-Contreras, J., Lucío, P., Ramírez, T., Salazar, J. T., Espinosa, A. R., Marín, C., Silvestre, J. L., Velázquez, E. A., Salcedo, J. C., Bouthillier, P., & Pérez, E. R. (2007). Hiperactividad pélvica: diagnóstico y tratamiento en el Hospital Central Militar.
66. Canapathy, M., Kurushev, J., Chitra, F., & Dash, M. (2019). Impact of Sensory Deprivation on Health Outcome. Acta Scientific Paediatrics. https://doi.org/10.31080/aspe.2019.02.0165
67. Canbulat, N., & Sonay, A. (2012). Pain Management and Nursing Approaches in Pediatric Oncology. InTech eBooks. https://doi.org/10.5772/32053
68. Capelas, M. L. (2008). Dor Total nos doentes com metastização óssea. https://doi.org/10.34632/cadernosdesaude.2008.2552
69. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
70. Carneiro, C., Chaves, M. L. D. S. C., Verardino, G. C., Drummond, A., Ramos‐e‐Silva, M., & Carneiro, S. (2011). Fatigue in psoriasis with arthritis.. PubMed.
71. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
72. Castaño-Cárcamo, M., Escobar-Córdoba, F., & Castro, J. R. D. (2014). [Restless Legs Syndrome : A Threat to the quality of life].. PubMed.
73. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
74. Charil, A., & Inglese, M. (2012). Predicting short-term conversion from CIS to MS. Neurology. https://doi.org/10.1212/wnl.0b013e31827dec22
75. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
76. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
77. Chaudhuri, К. R., & Meilak, C. (2004). What is restless legs syndrome?. CRC Press eBooks. https://doi.org/10.3109/9780203497500-5
78. Chen, L. (2021). Pain Intensity is associated with Self-Reported Disability and Adolescents with Musculoskeletal Pain.
79. Cherubini, G. B., Lowrie, M., & Anderson, J. R. (2008). Pelvic limb ataxia in the older dog 2. Painful conditions. In Practice. https://doi.org/10.1136/inpract.30.8.434
80. Cheung, C., & Wu, J. C. (2014). Genetic polymorphism in pathogenesis of irritable bowel syndrome. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v20.i47.17693
81. Chopra, P., Tinkle, B. T., Hamonet, C., Brock, I., Gompel, A., Bulbena, A., & Francomano, C. A. (2017). Pain management in the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31554
82. Chui-jie, W. (2011). Discussion on Treatment of Irritable Bowel Syndrome According to the Relationship Between Five Zang-organs and Emotions of TCM. Liaoning Zhongyiyao Daxue xuebao.
83. Cháves, A. A. D., & Guzmán, I. T. (2006). The Physical Therapy in the Rehabilitation of a Patient with Complex Regional Pain Syndrome. DOAJ (DOAJ: Directory of Open Access Journals).
84. Clark, J. T. (2002). What Do You Tell Parents who Ask why Their Child has Headaches?. American Orthoptic Journal. https://doi.org/10.3368/aoj.52.1.18
85. Clunie, G., Wilkinson, N., Nikiphorou, E., & Jadon, D. R. (2018). Evaluating rheumatological and musculoskeletal symptoms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198728252.003.0001
86. Coggan, J. S., Ocker, G. K., Prescott, S. A., & Sejnowski, T. J. (2011). Complex symptoms of demyelination and nerve damage explained by nonlinear dynamical analysis of conductance-based models. BMC Neuroscience. https://doi.org/10.1186/1471-2202-12-s1-p292
87. Coghill, D., Bonnar, S., Duke, S. E., Graham, J., & Seth, S. G. (2009). Pre-school problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0006
88. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
89. Constantinescu, C. S., & Lim, S. (2018). Weakness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0044
90. Conti, C. F. (2009). Tratamento da Síndrome das Pernas Inquietas idiopática: Revisão Sistemática e Metanálise..
91. Cook, L. (2018). Accommodating Persons with Physical Disability in the Lab. ACS symposium series. https://doi.org/10.1021/bk-2018-1272.ch004
92. Cooper, L., Copeland, S., Dailey, S., Downey, D., Petersen, M. C., Stimson, C., & Dyke, D. C. V. (2008). Feeding and swallowing dysfunction in genetic syndromes. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.19
93. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
94. Cordeiro, Q., Zung, S., & Vallada, H. (2008). Pisa syndrome induced by rapid increase and high dosage of risperidone. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2008000600026
95. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
96. Correll, C. U., Yu, X., Xiang, Y., Kane, J. M., & Masand, P. S. (2017). Biological treatment of Acute Agitation Or Aggression with Schizophrenia Or Bipolar Disorder in the Inpatient Setting. Annals of Clinical Psychiatry. https://doi.org/10.1177/104012371702900203
97. Costanzo, R. M., DiNardo, L. J., Reiter, E. R., & Doty, R. L. (2003). Head Injury and Taste. CRC Press eBooks. https://doi.org/10.1201/9780203911457-50
98. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
99. Cuijpers, P. (2010). Postpartum Depression. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0697
100. Cynthia, C., Ky, Cheung, Justin, & Wu (2014). Genetic polymorphism in pathogenesis of irritable bowel syndrome. 世界胃肠病学杂志：英文版（电子版）.
101. Dahlem, M. A., Mair, T., & Müller, S. C. (2004). Spatio-Temporal Aspects of a Dynamical Disease: Waves of Spreading Depression. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7895-1_42
102. Dalvi, A., Lyons, K. E., & Pahwa, R. (2006). Secondary Dystonia. CRC Press eBooks. https://doi.org/10.3109/9781420019988-19
103. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
104. Dash, S. K. (2016). Painless Limbs and Moving Extremities Syndrome: A Variant of Painful Moving Limbs and Extremities. British Journal of Medicine and Medical Research. https://doi.org/10.9734/bjmmr/2016/24712
105. Deantri, F., & Sawitri, A. A. S. (2020). PROPORSI STRES DAN GEJALA PSIKOSOMATIK PADA SISWA KELAS XII SEKOLAH MENENGAH ATAS DI KOTA DENPASAR. JURNAL BIOS LOGOS. https://doi.org/10.35799/jbl.10.1.2020.27465
106. Delitto, A., George, S. Z., Dillen, L. V., Whitman, J. M., Sowa, G., Shekelle, P., Denninger, T. R., & Godges, J. J. (2012). Low Back Pain. Journal of Orthopaedic and Sports Physical Therapy. https://doi.org/10.2519/jospt.2012.42.4.a1
107. Deluca, C. F., & Cashore, W. J. (2002). Congenital Familial Hypertonia. Clinical Pediatrics. https://doi.org/10.1177/000992280204100713
108. Demey, I., Zimerman, M., Allegri, R., Serrano, C., & Taragano, F. (2004). Neuropsychiatric symptoms of mild cognitive impairment. CRC Press eBooks. https://doi.org/10.3109/9780203492857-7
109. Derbyshire, S., & Bremner, J. D. (2009). Impact Of Functional Visceral And Somatic Pain/Stress Syndromes On Cingulate Cortex. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566960.003.0023
110. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
111. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
112. Ding, K., Gupta, P. K., & Diaz‐Arrastia, R. (2016). Epilepsy after Traumatic Brain Injury. CRC Press, Taylor and Francis Group eBooks.
113. DM, F. P. G. M., BSc, M. P. C. B., Boyd, D. M., & BSc, M. D. S. S. (2014). Major Medical Problems. https://doi.org/10.1002/9781118690345.ch8
114. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
115. Domínguez, M. R., Burgos, L. M., & Bergink, V. (2020). Perinatal Mood and Anxiety Disorders. Obstetrics and gynecology.. https://doi.org/10.1002/9781119450047.ch16
116. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
117. Duarte, M. D. S. (2019). Cerebellar dysfunction in cervical dystonia.
118. Duarte, M. L., Abreu, B. F. B. B. D., Ito, M. H., Costa, M. G. V., Prado, J. L. M. D. A., & Silva, M. D. Q. P. D. (2018). Bilateral sever´s disease–an uncommon finding. Journal of Pediatrics & Neonatal Care. https://doi.org/10.15406/jpnc.2018.08.00320
119. Dubois, B., Pillon, B., & Agid, Y. (1996). Testing cognition may contribute to the diagnosis of movement disorders. Neurology. https://doi.org/10.1212/wnl.46.2.329
120. Dugué, S. (2020). Les spécificités du syndrome douloureux régional complexe de type 1 (SDRC 1) en pédiatrie. Douleur et Analgésie. https://doi.org/10.3166/dea-2020-0141
121. During, E., & Winkelman, J. W. (2022). Restless Legs Syndrome and Psychiatric Issues. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0019
122. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
123. Egatz, R., Cabrero, B., & Garcı́a-Borreguero, D. (2007). Restless Legs Syndrome. CRC Press eBooks. https://doi.org/10.3109/9781420014693-15
124. Elgallab, J., Charvet, L., & Krupp, L. (2018). A Case of Cognitive and Behavioral Decline leading to Onset of Pediatric Onset Multiple Sclerosis (P2.316). Neurology. https://doi.org/10.1212/wnl.90.15_supplement.p2.316
125. Emilien, G., Durlach, C., Minaker, K. L., Winblad, B., Gauthier, S., & Maloteaux, J. (2004). Behavioral and psychological impairments. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7842-5_9
126. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Musculoskeletal medicine. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0015
127. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
128. Ensalada, L. H., Brigham, C. R., & Kertay, L. (2018). Somatization. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2018.julaug03
129. Erro, M. E., & Navarro, M. C. (2009). [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment].. PubMed.
130. Escobar, A. J. S. (2002). Avances en síndrome de intestino irritable. Revista Facultad Ciencias de la Salud: Universidad del Cauca.
131. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
132. Fahn, S., Greene, P., Ford, B., Bressman, S., & Frucht, S. J. (2009). Movement Disorders. https://doi.org/10.1007/978-1-57340-359-7_9
133. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
134. Farmer, A., McGuffin, P., & Williams, J. (2002). Validity, Reliability, and Utility. https://doi.org/10.1093/oso/9780192630803.003.0004
135. Farrer, F. (2008). Understanding Restless Legs Syndrome. Obstetrics and Gynaecology Forum.
136. Feinle, C., & Fried, M. (1997). [Functional dyspepsia].. PubMed.
137. Feteih, A., Zhang, L., Tardio, N., & Fein, M. (2021). Exercise-Induced Anaphylaxis (EIA) and Food-Dependent EIA (FDEIA). CRC Press eBooks. https://doi.org/10.1201/9781003174202-17
138. Fischer, T., Agar, M., Hosie, A., & Teodorczuk, A. (2020). Unpacking agitation in practice: a call for greater precision. Age and Ageing. https://doi.org/10.1093/ageing/afaa110
139. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
140. Flusser, D., Sukenik, S., & Abu‐Shakra, M. (2007). [Work related musculoskeletal disorders of the upper extremity].. PubMed.
141. Ford, B., & Pfeiffer, R. F. (2007). Pain Syndromes and Disorders of Sensation. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:255
142. Friedman, J. H., & Fernandez, H. H. (2000). THE NONMOTOR PROBLEMS OF PARKINSONʼS DISEASE. The Neurologist. https://doi.org/10.1097/00127893-200006010-00004
143. Funk, J., Goldman, S. M., & Christensen, V. (1997). Spinal stenosis. A common cause of podiatric symptoms. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/87507315-87-3-117
144. Galvez-Sánchez, C. M., Coba, P. D. L., Duschek, S., & Paso, G. A. R. D. (2020). Fibromyalgia Symptoms Overview. https://doi.org/10.32545/encyclopedia202009.0002.v2
145. Gameleira, G. H., & Barbosa, M. L. S. (2019). MANIFESTAÇÕES ATÍPICAS DAS CRISES EPILÉPTICAS. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas.
146. Garcia, J. I. O., Paylian, S., Cazare, A. I. G., & Pastor, I. (2019). Neuroinflammation as Part of a Possible Neuregeneration on a Patient with ASIA-A Scale Using Combinatorial Biologics: Bioquantine® and Allogeneic Mesenchymal Stem Cells. ACTA SCIENTIFIC MICROBIOLOGY. https://doi.org/10.31080/asmi.2019.02.0440
147. Garcia, J., Arguello, A. M., Momaya, A., & Ponce, B. A. (2020). &lt;p&gt;Sternoclavicular Joint Instability: Symptoms, Diagnosis And Management&lt;/p&gt;. Orthopedic Research and Reviews. https://doi.org/10.2147/orr.s170964
148. Garcı́a-Borreguero, D., Serrano, C., & Egatz, R. (2004). Diagnosis of the restless legs syndrome: the use of the sleep laboratory. CRC Press eBooks. https://doi.org/10.3109/9780203497500-13
149. Gautam, S., Jain, A., Gautam, M., Vahia, V., & Gautam, A. (2017). Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD). Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196975
150. Gaya, L. L. (2015). Pengaruh Aktivitas Olahraga, Kebiasaan Merokok, dan Frekuensi Duduk Statis dengan Kejadian Low Back Pain. Jurnal Agromedicine.
151. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
152. Ghaemi, S. N. (2018). Children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199995486.003.0028
153. Goodwin, D. W. (1969). Psychiatry and the mysterious medical complaint. JAMA. https://doi.org/10.1001/jama.209.12.1884
154. Graciès, J., Elovic, E., McGuire, J. J., & Simpson, D. M. (1997). Traditional pharmacological treatments for spasticity part I: Local treatments. Muscle & Nerve. https://doi.org/10.1002/(sici)1097-4598(1997)6+<61::aid-mus6>3.0.co;2-h
155. Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008). Anxiety disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544705.007
156. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
157. Group, M. T., Mackway‐Jones, K., Marsden, J., & Windle, J. (2006). Discriminator Dictionary. https://doi.org/10.1002/9780470757321.oth3
158. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
159. Gw, P. (2000). Restless legs syndrome. How to provide symptom relief with drug and nondrug therapies.. PubMed.
160. Hahn, J. S., & Sanger, T. D. (2004). Neonatal Movement Disorders. NeoReviews. https://doi.org/10.1542/neo.5-8-e321
161. Hakim, A. J., Clunie, G., & Haq, I. (2011). Evaluating musculoskeletal symptoms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199587186.003.0001
162. Hamdan, M., & Machin, A. (2009). Restless Legs Syndrome. Airlangga University Press eBooks.
163. Hana, M., & Ošlejšková (2006). Autismus. Neurologické, behaviorální a kognitivní projevy. Neurologie pro praxi.
164. Handel, M., & Brooks, P. (1997). Aches and pains in the elderly. Current therapeutics.
165. Harisudan, D. S. (2018). Restless leg syndrome in general population of an urban area in India. Journal of Medical Science And clinical Research. https://doi.org/10.18535/jmscr/v6i11.129
166. Hartman, T. O., Dowrick, C., Lam, C. L. K., Fortes, S., Clarke, D. D., & Usta, J. (2019). Medically unexplained symptoms. Routledge eBooks. https://doi.org/10.4324/9780429026386-4
167. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
168. Hernández-Porras, B. C., Plancarte, R., Alarcón-Barrios, S., & Sámano-García, M. (2017). Complex regional pain syndrome: A review. Cirugía y Cirujanos (English Edition). https://doi.org/10.1016/j.circen.2016.11.012
169. Hiestand, D. M., & Phillips, B. (2007). Restless Legs Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_8
170. Hisama, F. M., Dib‐Hajj, S. D., & Waxman, S. G. (2020). SCN9A Neuropathic Pain Syndromes.
171. Holden, S. K., & Hall, D. A. (2016). Ataxia. https://doi.org/10.1002/9781118474075.ch8
172. Hong, Y. (2008). The Relation of Restless Legs Syndrome with Diseases of Peripheral Nerves. Annals of Clinical Neurophysiology.
173. Hutchison, K., Cuevas, R., & Jankowiak, J. (2004). Restless legs. Neurology. https://doi.org/10.1212/wnl.63.12.e21
174. Hwang, J., & Jeong, S. H. (2009). Practical Diagnostic Approaches to Chronic Abdominal Pain in Children and Adolescents. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2009.52.3.271
175. Hyams, J. S. (1999). Functional gastrointestinal disorders. Current Opinion in Pediatrics. https://doi.org/10.1097/00008480-199910000-00001
176. Hyman, N. (2008). Restless legs syndrome: symptoms, management and new developments. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2008.69.3.28751
177. Inoue, Y. (2009). [Diagnosis and symptom rating scale of restless legs syndrome].. PubMed.
178. Irgebaeva, N., & Akmusaeva, M. (2020). ANXIETY OF THE PERSONEMOTIONAL STATUS. BULLETIN Series Psychology. https://doi.org/10.51889/2020-3.1728-7847.04
179. Ishii, A., Hayashi, A., Ohkoshi, N., Matsuno, S., & Shoji, S. (2004). Progressive encephalomyelitis with rigidity associated with anti-amphiphysin antibodies.. PubMed.
180. Istre, T. (2002). Use of actigraphy to objectively measure motor restlessness in Restless Legs Syndrome. https://doi.org/10.31390/gradschool_dissertations.2585
181. Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022). Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.21.0103
182. İpekdal, İ. H., Karadaş, Ö., Öz, O., & Ulaş, Ü. H. (2011). Restless Legs Syndrome Secondary to Sacral Zona Zoster. Journal of Pain and Symptom Management. https://doi.org/10.1016/j.jpainsymman.2010.11.007
183. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2007.131045
184. Japardi, I. (2002). ASPEK NEUROLOGIK GANGGUAN BERJALAN.
185. Jensen, T. S. (2002). An improved understanding of neuropathic pain. European Journal of Pain. https://doi.org/10.1016/s1090-3801(02)90002-9
186. Joseph, B. (2015). Radial club hand. CRC Press eBooks. https://doi.org/10.1201/b19226-39
187. Jovanović, J., Lazaridis, K., & Stefanović, V. (2006). THEORETICAL APPROACHES TO PROBLEM OF OCCUPATIONAL STRESS. Acta Facultatis Medicae Naissensis.
188. Kanchanatawan, B., & Kasantikul, D. (2007). Antipsychotic-induced tardive movement disorders: a series of twelve cases.. PubMed.
189. Kane, I., Light, M. J., Osewa, I., Nobler, M. S., & Siddiqi, N. (2017). Acute psychosis with manic features in patient with Fahrs syndrome: A Case report and Clinical review. Neuropsychiatry. https://doi.org/10.4172/neuropsychiatry.1000207
190. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
191. Katz, P. (2006). Function, Disability, and Psychological Well-Being. KARGER eBooks. https://doi.org/10.1159/000095365
192. Kauffmann, B., Wermuth, M., Spranger, S., Rautenberg, M., & Rating, T. (2019). ATP1A3-associated Disease as a Differential Diagnosis to Stroke in Children - An Unusual Case with Degenerative Cerebellar Atrophy. Neuropediatrics. https://doi.org/10.1055/s-0039-1698193
193. Kavan, M., Elsasser, G. N., & Barone, E. J. (2012). The physician's role in managing acute stress disorder.. PubMed.
194. Kelmanson, I. A. (2006). Infant temperament characteristics related to sudden infant death syndrome and its risk factors. Early Child Development and Care. https://doi.org/10.1080/03004430500147292
195. Kempkes, U., Fischer, M., Haage, P., & Isenmann, S. (2008). Recurrent orbital myositis mimicking sixth nerve palsy. Klinische Neurophysiologie. https://doi.org/10.1055/s-2008-1072856
196. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
197. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
198. Klepitskaya, O. (2016). Restless Leg Syndrome. https://doi.org/10.1002/9781118474075.ch9
199. Kondo, T., & Ishiguchi, H. (2007). 3. Drug Induced Dyskinesia. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.96.1621
200. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
201. Krysiak, W., Szabowski, S., Stępień, M., Krzywkowska, K., Krzywkowski, A., & Marciniak, P. (2008). Hiccups as a myocardial ischemia symptom. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.338
202. Kumar, S., & Browne, M. O. (2003). What are the effects of drug treatments for panic disorder?. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.6.2.34
203. Kumawat, B., Sharma, C. M., Tripathi, G., Ralot, T. K., & Dixit, S. (2007). &lt;i&gt;Wilson's disease&lt;/i&gt; presenting as isolated obsessive-compulsive disorder. Indian Journal of Medical Sciences. https://doi.org/10.4103/0019-5359.37047
204. Kurlemann, G., & Fiedler, B. (2006). Dissociative disorders - from a neuropediatric point of view. Neuropediatrics. https://doi.org/10.1055/s-2006-973972
205. Labat, J., Riant, T., Robert, R., Amarenco, G., Lefaucheur, J., & Rigaud, J. (2007). Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourology and Urodynamics. https://doi.org/10.1002/nau.20505
206. Lanier, J. B., Mote, M. B., & Clay, E. C. (2011). Evaluation and management of orthostatic hypotension.. PubMed.
207. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
208. Lee‐Chiong, T. (2008). Evaluation of Sleep, and Sleep Disorders. https://doi.org/10.1093/oso/9780195306590.003.0002
209. Lee‐Chiong, T. (2008). Medications and Their Effects on Sleep. https://doi.org/10.1093/oso/9780195306590.003.0016
210. Lee‐Chiong, T. (2008). Parasomnias and Abnormal Sleep-Related Movements. https://doi.org/10.1093/oso/9780195306590.003.0007
211. Lee‐Chiong, T. (2008). Psychiatric and Behavioral Disorders. https://doi.org/10.1093/oso/9780195306590.003.0011
212. Lee‐Chiong, T. (2008). Restless Legs Syndrome and Periodic Limb Movement Disorder. https://doi.org/10.1093/oso/9780195306590.003.0008
213. Lee‐Chiong, T. (2008). Sleep In The Medical Disorders. https://doi.org/10.1093/oso/9780195306590.003.0009
214. Leggin, B. G., Shaffer, M. A., Neuman, R. M., Williams, G. R., & Annotti, J. P. I. (2003). Relationship of the Penn Shoulder Score with Measures of Range of Motion and Strength in Patients with Shoulder Disorders: A Preliminary Report.
215. Leiby, A., & Chitkara, D. K. (2012). Functional Dyspepsia. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-709-9_33
216. Leoni, M. C., Pizzo, D., Rundo, B., Tasso, G., & Marchi, A. (2009). Atassia in ex-prematuro: un caso pediatrico. Bollettino della Società Medico Chirurgica di Pavia. https://doi.org/10.6092/2039-1404.122.404
217. Leszek, J. (2021). Parkinson’s disease with concomitant generalized anxiety disorder – case report. Medycyna Faktów. https://doi.org/10.24292/01.mf.0421.14
218. LeWitt, P. A. (2018). Post‐traumatic Origin of Unilateral Restless Leg Syndrome. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12594
219. LEÓN-CARRIÓN, M. D. R. D. M. J. (2006). Low-level responsive states. Taylor & Francis eBooks. https://doi.org/10.4324/9780203965238-15
220. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
221. Li, Z., Goh, S. N., Teo, Y. W., & How, C. H. (2023). Management of intimate partner abuse. Singapore Medical Journal. https://doi.org/10.4103/singaporemedj.smj-2021-452
222. Lim, S., Wadia, P. M., Armstrong, M. J., Schenck, C. H., & Lang, A. E. (2015). Augmented Restless Legs Syndrome with Marked Hyperkinesias and Impulsive‐Compulsive Behaviors. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12299
223. Loconte, S. (2019). Primary fibromyalgia syndrome: A new holistic approach [abstract]. Journal of Ozone Therapy. https://doi.org/10.7203/jo3t.3.4.2019.15526
224. Loprinzi, C. L., Maddocks‐Christianson, K., Wolf, S. L., Rao, R. D., Dyck, P. J. B., Mantyh, P. W., & Dyck, P. J. B. (2007). The Paclitaxel Acute Pain Syndrome: Sensitization of Nociceptors as the Putative Mechanism. The Cancer Journal. https://doi.org/10.1097/ppo.0b013e31815a999b
225. Loyola, D. P. (2010). Truques sensoriais em diferentes tipos de distonia e no espasmo hemifacial.
226. Luthra, M. (2017). Depression: Current Scenario with reference to India. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2017.v29i01.001
227. Madrid, P. A., Grant, R., Reilly, M. J., & Redlener, N. B. (2006). Challenges in Meeting Immediate Emotional Needs: Short-term Impact of a Major Disaster on Children's Mental Health: Building Resiliency in the Aftermath of Hurricane Katrina. PEDIATRICS. https://doi.org/10.1542/peds.2006-0099u
228. Madsen, H., & Drewes, A. M. (2006). [Abdominal pain].. PubMed.
229. Malagelada, J. R. (2004). Gastrointestinal motility and perception disorders re-visited. Revista Española de Enfermedades Digestivas. https://doi.org/10.4321/s1130-01082004000700005
230. Malin, H., & Saleh, F. M. (2007). Paraphilias: Clinical and Forensic Considerations.
231. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
232. Mano, T., & Thomas, R. J. (2018). Anatomo-functional basis of restless legs syndrome. Neurology. https://doi.org/10.1212/wnl.0000000000005573
233. Mansur, A., Castillo, P. R., Cabrero, F. R., & Bokhari, S. R. A. (2019). Restless Leg Syndrome.
234. Mao, J. (2017). Challenges of managing chronic pain. BMJ. https://doi.org/10.1136/bmj.j741
235. Marchand, D. K., & McCormack, S. (2019). Codeine for Acute Pain in Patients Undergoing Orthopedic Surgery: A Review of Clinical Effectiveness [Internet].
236. Massey, T. H., & Robertson, N. P. (2020). Restless legs syndrome: causes and consequences. Journal of Neurology. https://doi.org/10.1007/s00415-019-09682-6
237. Master, C. L., Bacal, D., Grady, M. F., Hertle, R. W., Shah, A. S., Strominger, M. B., Whitecross, S., Bradford, G. E., Lum, F., & Donahue, S. P. (2022). Vision and Concussion: Symptoms, Signs, Evaluation, and Treatment. PEDIATRICS. https://doi.org/10.1542/peds.2021-056047
238. Mathis, J., & Grandjean, P. (2002). Das Restless-Legs-Syndrom in der Praxis. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. https://doi.org/10.4414/smf.2002.04412
239. Mathis, S. L. (2018). FACTORS ASSOCIATED WITH MOBILITY APPREHENSION IN AMPUTEES. Canadian Prosthetics & Orthotics Journal. https://doi.org/10.33137/cpoj.v1i2.32040
240. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
241. Maya, G. C. (2011). Pica: el síntoma olvidado. Medicina & Laboratorio.
242. McCracken, L. M. (2008). Psychological effects of chronic pain: an overview. CRC Press eBooks. https://doi.org/10.1201/b13472-13
243. McPherson, S. (2004). Apathy in Alzheimer’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-661-4_44
244. Mearin, F., Ciriza, C., Mínguez, M., Rey, E., Mascort, J., Peña, E. D. L., Cañones, P., & Júdez, J. (2017). Guía de práctica clínica del síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: tratamiento. (Parte 2 de 2). Atención Primaria. https://doi.org/10.1016/j.aprim.2017.01.003
245. Medcalf, P., & Bhatia, K. P. (2006). Restless legs syndrome. BMJ. https://doi.org/10.1136/bmj.333.7566.457
246. Medina, A. B., Roniger, D. D. G., Alonzo, G. M., & Genchi, A. J. (2012). Síndrome de piernas inquietas en comorbilidad con trastornos psiquiátricos y enfermedad médica: un caso ilustrativo. Psiquis - Hospital Psiquiátrico Fray Bernardino Alvarez.
247. Medina, S., & Fernando, D. (2019). Caso Christopher : El deseo, de deseo imposible en la neurosis obsesiva..
248. Melo-Dias, C., Apóstolo, J., & Cardoso, D. (2014). Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2014-1639
249. Mendell, J. R., & Sahenk, Z. (2003). This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations. Painful Sensory Neuropathy.
250. Michel, P. (2006). Neurologist-in-training. Schweizer Archiv für Neurologie und Psychiatrie. https://doi.org/10.4414/sanp.2006.01727
251. Miller, A. E., DeAngelis, T. M., Fabian, M., & Sand, I. K. (2018). Recurrent Ulcers and a Brainstem Lesion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190693190.003.0007
252. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
253. Millin, M. G., Shah, S. M., & Wright, D. G. (2003). Nontraumatic Spinal Cord Emergencies. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.027
254. Min-hui, D. (2007). Research Progress of Delayed-Onset Muscle Soreness.
255. Mizuno, Y. (1997). [Concept and diagnostic criteria of Parkinson's disease and parkinsonism].. PubMed.
256. Molla, L., Preza, K., & Simaku, A. (2021). Low Back Pain Diagnostic Approach. Medicus. https://doi.org/10.58944/bcsf1353
257. Moore, A. P. (2000). Pergolide reduced involuntary periodic leg movements and improved sleep in the restless legs syndrome. Evidence-Based Medicine. https://doi.org/10.1136/ebm.5.1.21
258. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
259. Morrison, M. C. T. (2003). WHIPLASH – WHY THE ARGUMENTS?. Orthopaedic Proceedings.
260. Morrison, M. C. T. (2018). WHIPLASH – WHY THE ARGUMENTS?. Orthopaedic Proceedings.
261. Motta, M. P., Quadros, A. A. J., Ferreira, L. S., & Oliveira, A. S. B. (2019). Fatigue in Post-Polio Syndrome. Brazilian Journal of Biological Sciences. https://doi.org/10.21472/bjbs.061203
262. Mucci, V., Sussetto, M., Ranieri, M., Cavuscens, S., Fornos, A. P., & Guinand, N. (2019). [The Mal de Débarquement Syndrome].. PubMed.
263. Murphy, P. M., & Murphy, C. A. (2011). Hyperventilation as a Simple Cure for Severe Exercise-Associated Muscle Cramping. Pain Medicine. https://doi.org/10.1111/j.1526-4637.2011.01112.x
264. Na, I., & Volel, B. A. (2002). [Clinical aspects of "folie du doute"].. PubMed.
265. Nambu, A. (2012). Pathophysiology of movement disorders. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.52.1198
266. Naser, M., Naser, M. M., & Shehata, L. H. (2021). Irritable Bowel Syndrome (IBS) Clinical Review. International Journal of Progressive Sciences and Technologies. https://doi.org/10.52155/ijpsat.v27.1.3167
267. Nava, G. M. (2018). Depression: From Sorrow to Melancholia. Scholarly Journal of Psychology and Behavioral Sciences. https://doi.org/10.32474/sjpbs.2018.01.000106
268. Ness, T. J. (2008). Chronic abdominal, groin, and perineal pain of visceral origin. CRC Press eBooks. https://doi.org/10.1201/b13472-40
269. Neto, B. P. F. (2009). Catatonia with Left Temporal Lesion on MRI: Crossing Borders. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70960-5
270. Nomura, Y. (1997). [The clinical characteristics of involuntary movements in childhood].. PubMed.
271. Norton, C., Williams, J., Taylor, C., Nunwa, A., & Whayman, K. (2008). Chapter 19 Bowel care and vulnerable groups. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199298655.003.0019
272. Oikawa, S. Y., Holloway, T. M., & Phillips, S. M. (2019). The Impact of Step Reduction on Muscle Health in Aging: Protein and Exercise as Countermeasures. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2019.00075
273. Olshansky, B., Feigofsky, S., & Cannom, D. S. (2018). Is it bradycardia or something else causing symptoms?. HeartRhythm Case Reports. https://doi.org/10.1016/j.hrcr.2018.09.011
274. Oyama, G., Okun, M. S., Ashizawa, T., & Malaty, I. A. (2011). Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.79
275. Oyama, G., Okun, M. S., Ashizawa, T., & Malaty, I. A. (2011). Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome.. PubMed. https://doi.org/10.7916/d8xg9pwk
276. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
277. Ozhek, S. R. (2007). THE PROCESS OF SEPARATION AND INDIVIDUATION AS THE RISK FACTOR IN PSYCHOSOCIAL DEVELOPMENT OF PERSONS WITH PHYSICAL DISABILITIES. DOAJ (DOAJ: Directory of Open Access Journals).
278. O’Connor, F. G., & Levine, B. D. (2015). Syncope in Athletes of Cardiac Origin. Current Sports Medicine Reports. https://doi.org/10.1097/01.csmr.0000465136.70746.5b
279. O’Keeffe, S. T. (1996). Restless Legs Syndrome. Archives of Internal Medicine. https://doi.org/10.1001/archinte.1996.00440030025004
280. O’Regan, D., & Anderson, K. N. (2020). Restless legs syndrome and periodic limb movements of sleep. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2019.0319
281. Pacchetti, C., Cristina, S., Mancini, F., Fundarò, C., Corengia, E., Martignoni, E., & Nappi, G. (2000). Sintomi non motori nella malattia di Parkinson: Procedure per la diagnosi, la terapia e la riabilitazione.
282. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
283. Papazian, Ó., & Alfonso, I. (2002). Polirradiculoneuropatías autoinmunes agudas. Revista de Neurología. https://doi.org/10.33588/rn.3402.2001337
284. Papuc, I., LĂCĂTUŞ, R., Timen, A. M., Coşa, L., & Purdoiu, R. C. (2007). CANINE ANXIETY SINDROME BY DOG - OWNER SEPARATION TREATMENT. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine. https://doi.org/10.15835/buasvmcn-vm:64:1-2:2397
285. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
286. Park, H. S., Joo, E. Y., & Hong, S. B. (2009). Sleep onset Insomnia. Journal of Korean Sleep Research Society. https://doi.org/10.13078/jksrs09015
287. Park, J. H., Kim, H.-C., Lee, J. H., Kim, J. S., Roh, S. Y., Yi, C. H., Kang, Y. K., & Kwon, B. S. (2009). Development of Korean Academy of Medical Sciences Guideline for Rating Physical Disability of Upper Extremity. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2009.24.s2.s288
288. Parvataneni, S., & Duncan, M. (2020). S2043 Anxiolytic - A Gastric Fundus Relaxing Agent for Epigastric Pain Syndrome. The American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000000868
289. Parčina, M. (2017). ORGANIZACIJA RADA USTANOVE ZA ZAPOŠLJAVANJE, RAD I PROFESIONALNU REHABILITACIJU OSOBA S INVALIDITETOM.
290. Patel, A., & Khan, S. (2019). Restless Legs Syndrome in Women with Comorbid Psychiatric Disease. Psychiatric Annals. https://doi.org/10.3928/00485713-20191106-03
291. Patil, S. R. (2018). TAILA DHARA IN NIDRANASHA W.S.R. TO INSOMNIA. National Journal of Research in Ayurved Science. https://doi.org/10.52482/ayurlog.v6i06.204
292. Paulin, L. F. R. D. S., Reis, E. F. D., & Rodrigues, E. P. (2008). Síndrome de descontinuação dos antidepressivos.
293. Pavone, P., Corsello, G., Ruggieri, M., Marino, S., Marino, S. D., & Falsaperla, R. (2018). Benign and severe early-life seizures: a round in the first year of life. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/s13052-018-0491-z
294. Paz, T. D. S. R., Silva, A. E. L., Martins, N. I. M., Brito, V. L. S. D., Leite, M. A. A., & Corrêa, C. L. (2019). Congelamento da marcha e de membros superiores na doença de Parkinson. Revista Brasileira de Neurologia.
295. Pearson, O., Busse, M., Deursen, R. W. M. V., & Wiles, C. M. (2004). Quantification of walking mobility in neurological disorders. QJM. https://doi.org/10.1093/qjmed/hch084
296. Pella, R. D., Mukundan, L. P., & Szabó, C. Á. (2014). Juvenile Myoclonic Epilepsy — A Maturation Syndrome Coming of Age. InTech eBooks. https://doi.org/10.5772/58372
297. Perkins, M., Lettieri, C. J., & Holley, A. B. (2010). Pharmacotherapy Options in Restless Legs Syndrome. Clinical Medicine Reviews in Therapeutics. https://doi.org/10.4137/cmrt.s4665
298. Pickard, H. (2011). What Is Personality Disorder?. Philosophy, psychiatry & psychology. https://doi.org/10.1353/ppp.2011.0040
299. Pinder, R. M. (2006). Restless legs is a medical disorder and can be treated. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/nedt.2006.2.4.391
300. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, К. R., & Piccini, P. (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
301. Porter, K. A., Porcari, C., Koch, E. I., Fons, C. E., & Spates, C. R. (2006). In vivo exposure treatment for agoraphobia.. The Behavior Analyst Today. https://doi.org/10.1037/h0100161
302. Possover, M., & Forman, A. (2012). Voiding Dysfunction Associated with Pudendal Nerve Entrapment. Current Bladder Dysfunction Reports. https://doi.org/10.1007/s11884-012-0156-5
303. Poulain, P. (1996). Assessment of chronic pain in children. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-199603000-00048
304. Powers, S. W., Gilman, D. K., & Hershey, A. D. (2006). Headache and Psychological Functioning in Children and Adolescents. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00583.x
305. Pridmore, S. (2019). Mood and affect. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.12836
306. Provini, F., Vetrugno, R., & Montagna, P. (2008). Restless legs syndrome: effects on cognitive functioning, memory, and psychomotor performance. CRC Press eBooks. https://doi.org/10.3109/9780203091715-54
307. Quesada, S. D. S., Silva, L. F., & Brauer, A. G. (2019). PILATES E FIBROMIALGIA UMA REVISÃO DE LITERATURA. Anais do EVINCI - UniBrasil.
308. Rabins, P. V., & Slavney, P. R. (2008). Overview of Psychiatric Symptoms and Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195309430.003.0008
309. Raju, S., Medarametla, S., & Boraiah, N. (2020). Dystonia and Hereditary Motor Sensory Neuropathy <scp>6B</scp> Due to <scp><i>SLC25A46</i></scp> Gene Mutations. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13139
310. Rasquin‐Weber, A., Hyman, P. E., Cucchiara, S., Fleisher, D. R., Hyams, J. S., Milla, P. J., & Staiano, A. (1999). Childhood functional gastrointestinal disorders. Gut. https://doi.org/10.1136/gut.45.2008.ii60
311. Rasulić, L., Ivanović, S., Baščarević, V., & Šimić, V. (2004). Fantomski bol i postraumatska bolna stanja. Acta chirurgica iugoslavica. https://doi.org/10.2298/aci0404069r
312. Raux, M., Karroum, E. G., Arnulf, I., & Riou, B. (2010). Case Scenario: Anesthetic Implications of Restless Legs Syndrome. Anesthesiology. https://doi.org/10.1097/aln.0b013e3181de2d66
313. Ray, S., Pal, P. K., & Yadav, R. (2020). Non-motor symptoms in cervical dystonia: A review. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_27_20
314. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
315. Reid, K. J., & Zee, P. C. (2004). Circadian Rhythm Disorders. Seminars in Neurology. https://doi.org/10.1055/s-2004-835063
316. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
317. Reinthal, M., Lund, I., & Lundeberg, T. (2011). Infantile Colic: More than the Mother. Acupuncture in Medicine. https://doi.org/10.1136/acupmed-2011-010096
318. Rennie, J. M., Hagmann, C., & Robertson, N. J. (2008). The baby with a suspected seizure. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544750.009
319. Reuter, I., Mehnert, S., Oechsner, M., & Engelhardt, M. (2011). Cognitive Rehabilitation in Parkinson's Disease Using Neuropsychological Training, Transfer Training and Sports Therapy. InTech eBooks. https://doi.org/10.5772/17685
320. Revivo, G., Amstutz, D., & Haas, M. (2020). Chronic Pain. Pediatric Rehabilitation. https://doi.org/10.1891/9780826147073.0009
321. Richardson, M. (2003). Anxiety in childhood. https://doi.org/10.4225/50/5552e75abb9b8
322. Rizk, M. S., Nader, E. A., Karam, C., & Ayoub, C. M. (2011). Low back pain as perceived by the pain specialist.. PubMed.
323. Robinson, C. P., & Hocker, S. E. (2019). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0098
324. Roca, D. J. (2008). Algunos aspectos del espectro Autista. Un trastorno inusitadamente frecuente y doloroso.. Medicina-buenos Aires.
325. Rodrigo, L. (2018). Commentary: “Gluten Ataxia and their relationships with Celiac Disease and Non-Celiac Gluten Sensitivity”. Pharmaceutics and Pharmacology Research. https://doi.org/10.31579/2693-7247/002
326. Rodrigues, R. N., Rodrigues, A. A. A. D. A. E. S., Corso, J. T., & Peixoto, T. F. (2008). Restless legs syndrome associated with cardiac failure and aggravated after valvular replacement: Vesper's curse?. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2008000400019
327. Rodríguez, R. M., López-Bastías, J. L., Camarena, I. G., & Goicoechea, C. (2018). Effects on self-efficacy for managing chronic pain and fatigue of rheumatoid arthritis following a group educational programme (based) on occupational therapy. International Physical Medicine & Rehabilitation Journal. https://doi.org/10.15406/ipmrj.2018.03.00132
328. Rogers, H., & Arango‐Lasprilla, J. C. (2002). Signos y síntomas comportamentales y psicológicos más comunes en la enfermedad de Alzheimer. Suma Psicológica. https://doi.org/10.14349/sumapsi2002.225
329. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
330. Roussy, G., & Dejerine, J. (1969). The Thalamic Syndrome. Archives of Neurology. https://doi.org/10.1001/archneur.1969.00480110124015
331. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
332. Rowland, D. L., & Incrocci, L. (2008). Appendix: Alphabetical Listing of DSM‐IV Sexual and Gender Identity Disorders Reviewed. https://doi.org/10.1002/9781118269978.app1
333. Roy, B. A. (2015). Overreaching/Overtraining. ACSMʼs Health & Fitness Journal. https://doi.org/10.1249/fit.0000000000000100
334. Rubin, J. N. (2018). CONSISTENT PATTERNS IN SECONDARY HEALTH EFFECTS OF DISASTERS. Abstracts with programs - Geological Society of America. https://doi.org/10.1130/abs/2018am-319679
335. Rubí, P. (2018). Síndrome de piernas inquietas/Willis Ekbom desde la mirada del psiquiatra. Revista médica de Chile. https://doi.org/10.4067/s0034-98872018000901041
336. Ryan, M., & Slevin, J. T. (2007). Restless Legs Syndrome. Journal of Pharmacy Practice. https://doi.org/10.1177/0897190007310914
337. Ríos, C. G., Sánchez, M. V., Campos, M. L. P., Lozano, C. F., & Montañés, P. M. (2021). Mitos y realidades sobre la enuresis en pediatría.. Revista Sanitaria de Investigación.
338. Sabbineni, A. (2020). Short Communication on Restless Leg Syndrome. Journal of Sleep Disorders Treatment & Care. https://doi.org/10.37532/jsdtc.2020.9(4).237
339. Sabol, M. (2017). Procjena aktivnosti svakodnevnog života osoba s cerebralnom paralizom.
340. Sadat, S. A., Chowdhury, N. M., & Baten, R. B. A. (2017). Burning Mouth Syndrome: A Review. Journal of Bangladesh College of Physicians and Surgeons. https://doi.org/10.3329/jbcps.v34i3.32348
341. Sahli, H., Seddik, L., & Rémy, P. (2018). [Non-motor symptoms of Parkinson disease and their management].. PubMed.
342. Sakalauskaitë-Juodeikienë, E., & Masaitienė, R. (2018). Naujas nemigos apibrėžimas, etiopatogenezė, diagnostikos ir gydymo algoritmas. Neurologijos seminarai. https://doi.org/10.29014/ns.2018.20
343. Salcedo, A. K. M., Escobar, J. C. C., & Diaz, L. Y. V. (2019). Ansiedad dental en adultos en la clínica odontológica de la universidad cooperativa de colombia de pasto.
344. Salim, M. S., & Anjum, Q. (2003). Role of nerve blocks in chronic pain managementi. Rawal Medical Journal.
345. Sanger, T. D., Chen, D., Fehlings, D., Hallett, M., Lang, A. E., Mink, J. W., Singer, H. S., Alter, K. E., Ben‐Pazi, H., Butler, E. E., Chen, R., Collins, A., Dayanidhi, S., Forssberg, H., Fowler, E., Gilbert, D. L., Gorman, S. L., Gormley, M., Jinnah, H. A., ... Valero‐Cuevas, F. J. (2010). Definition and classification of hyperkinetic movements in childhood. Movement Disorders. https://doi.org/10.1002/mds.23088
346. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
347. Santos, B., Oliveira, A. S., Canhão, C., Teixeira, J., Dias, A., Pinto, P., & Bárbara, C. (2008). [Restless legs syndrome].. PubMed.
348. Sass, L. A., Borda, J. P., Madeira, L., Pienkos, E., & Nelson, B. (2018). Varieties of Self Disorder: A Bio-Pheno-Social Model of Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sby001
349. Sathe, S. (2020). Orthopaedics-2020: Role of epidural steroid plus local anesthetic in lumbar canal stenosis in older adults. journal of Clinical & Experimental Orthopaedics.
350. Scheiber-Nogueira, M.-C. (2009). Troubles sexuels et syndrome de la queue-de-cheval Sexual dysfunction in cauda equina syndrome.
351. Schiffter, R. (1988). ["Abnormal" neurologic findings in the "healthy" elderly].. PubMed.
352. Schwarz, J., & Trenkwalder, C. (1996). Restless Legs Syndrom: Therapie mit L-Dopa bzw. L-Dopa-Retardformen. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-1017828
353. Seah, M., & Khanduja, V. (2017). Hip disorders. CRC Press eBooks. https://doi.org/10.1201/9781315384030-6
354. Seifert, B., Lukáš, K., Charvátová, E., Vojtíšková, J., Koudelka, T., Hep, A., Bureš, J., Jirásek, V., & Dítě, P. (2007). Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006.
355. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
356. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
357. Shamsi, S., & Khan, S. (2019). Use of Pain Assessment Tools in Physiotherapy.
358. Share, H. W. (2011). AUTISM SPECTRUM DISORDER.
359. Sharma, L., Chmiel, J. S., Almagor, O., Felson, D. T., Guermazi, A., Roemer, F. W., Lewis, C. E., Segal, N. A., Torner, J. C., Cooke, T., Hietpas, J., Lynch, J., & Nevitt, M. C. (2012). The role of varus and valgus alignment in the initial development of knee cartilage damage by MRI: the MOST study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2011-201070
360. Shenoy, R., Roberts, K. E., & Anand, P. (2008). Peripheral neuropathies. CRC Press eBooks. https://doi.org/10.1201/b13472-25
361. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Chorea and Ballism. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0004
362. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Definition and Classification of Involuntary Movements. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0001
363. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Disorders of Increased Muscle Stiffness or Overactivity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0009
364. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Sleep-Related Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0008
365. Shin, J. E., Park, K. S., & Nam, K. (2019). Chronic Functional Constipation. Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2019.73.2.92
366. Shrivastava, D. (2022). Does the Patient Have Abnormal Movements at Night?. CRC Press eBooks. https://doi.org/10.1201/9781003093381-11
367. Shrivastava, D. (2022). Pharmacological Agents Used in Various Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003093381-28
368. Siemiński, M., & Zemojtel, L. (2019). Acute Drug-Induced Symptoms of Restless Legs Syndrome in an Emergency Department. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.7774
369. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
370. Sitaru, C., Cristea, V., & Florea, S. (1999). Restless legs syndrome--relevant aspects for internal medicine specialists.. Romanian Journal of Internal Medicine.
371. Sizer, P. S., Phelps, V., Brismée, J. M., Cook, C., & Dedrick, L. (2004). Ergonomic Pain––Part 2: Differential Diagnosis and Management Considerations. Pain Practice. https://doi.org/10.1111/j.1533-2500.2004.04209.x
372. Slack, C. B., & Landis, C. A. (2006). Improving Outcomes for Restless Legs Syndrome. The Nurse Practitioner. https://doi.org/10.1097/00006205-200605000-00005
373. Small, G. A., & Chuirazzi, D. M. (2003). Weakness. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.008
374. Smith, H. S. (2009). Proton Pump Inhibitors and Pain. Pain Physician. https://doi.org/10.36076/ppj.2009/12/1013
375. Smith, H. S. (2011). Fibromyalgia: An Afferent Processing Disorder Leading to a Complex Pain Generalized Syndrome. Pain Physician. https://doi.org/10.36076/ppj.2011/14/e217
376. Solorzano, J. M. M., Quijije, J. K. L., Pin, T. D. R. M., & Vera, J. V. C. (2020). Causas y efectos de los pacientes diagnosticados con el mal de Parkinson. RECIMUNDO. https://doi.org/10.26820/recimundo/4.(4).octubre.2020.496-508
377. Sommer, C., Cruccu, G., Anand, P., Attal, N., Baron, R., Garcı́a-Larrea, L., Haanpää, M., Jensen, T. S., Serra, J., & Treede, R. (2010). Assessment of Neuropathic Pain. https://doi.org/10.1002/9781444328394.ch8
378. Song, S. Y., Pei, Y., Tippett, S. R., Lamichhane, D., Zallek, C. M., & Hsiao‐Wecksler, E. T. (2018). Validation of a Wearable Position, Velocity, and Resistance Meter for Assessing Spasticity and Rigidity. 2017 Design of Medical Devices Conference. https://doi.org/10.1115/dmd2018-6906
379. Sparmann, M., & Müller, D. (2017). Ungewöhnliche attackenweise Einschlafstörungen Unusual attack-like sleep onset disturbances. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627037
380. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
381. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
382. Sponseller, P. D. (1996). Evaluating the child with back pain.. PubMed.
383. Staab, J. P., Eckhardt‐Henn, A., Horii, A., Jacob, R. G., Strupp, M., Brandt, T., & Bronstein, A. M. (2017). Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-170622
384. Stafie, C. S., & Stafie, I. I. (2019). POST COITAL ALLERGY – A CASE REPORT OF POST ORGASMIC ILLNESS SYNDROME. The Medical-Surgical Journal.
385. Stewart, J. M., Boris, J. R., Chelimsky, G., Fischer, P. R., Fortunato, J. E., Grubb, B. P., Heyer, G. L., Jarjour, I. T., Medow, M. S., Numan, M. T., Pianosi, P. T., Singer, W., Tarbell, S. E., & Chelimsky, T. (2017). Pediatric Disorders of Orthostatic Intolerance. PEDIATRICS. https://doi.org/10.1542/peds.2017-1673
386. Stojanović, M., Rančić, N., & Stojanović, M. (2019). BURNOUT SYNDROME AT WORKPLACE AMONG DOCTORS. Acta Medica Medianae. https://doi.org/10.5633/amm.2019.0420
387. Stone, J., & Sharpe, M. (2020). Functional neurological symptom disorder (conversion disorder). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0133
388. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
389. Strupp, M., Kremmyda, O., Adamczyk, C., Böttcher, N., Muth, C., Yip, C. W., & Brémovà-Ertl, T. (2014). Central ocular motor disorders, including gaze palsy and nystagmus. Journal of Neurology. https://doi.org/10.1007/s00415-014-7385-9
390. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
391. Su, N., Yang, J., Xie, Y., Du, X., Chen, H., Zhou, H., & Chen, L. (2019). Bone function, dysfunction and its role in diseases including critical illness. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.27063
392. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
393. Summerton, N. (2004). Evidence in practice — number 4: Restless legs. British Journal of General Practice.
394. Sutcliffe, M. M. L. (2019). Irritable bowel syndrome. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738019855099
395. Suzuki, K., Fujita, H., Watanabe, Y., Matsubara, T., Kadowaki, T., Sakuramoto, H., Hamaguchi, M., Nozawa, N., & Hirata, K. (2019). Leg restlessness preceding the onset of motor symptoms of Parkinson disease. Medicine. https://doi.org/10.1097/md.0000000000016892
396. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
397. Tagaya, H., Murayama, N., & Hakamata, Y. (2012). [Definitions and clinical classifications of sleep disorders].. PubMed.
398. Takada, S. (2020). Prevention and diagnosis of neuropathy during dental treatment. Japanese Journal of Oral & Maxillofacial Surgery. https://doi.org/10.5794/jjoms.66.530
399. Talley, N. J., Goodsall, T. M., & Potter, M. (2017). Functional dyspepsia. Australian Prescriber. https://doi.org/10.18773/austprescr.2017.066
400. Talmage, J. B., Blaisdell, J., Eskay-Auerbach, M., & Brigham, C. R. (2014). Impairment Rating for Non-Specific Back Pain Under the AMA Guides, Sixth Edition: Medical Perspective. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2014.marapr01
401. Tan, S. N., & Lim, E. C. (2020). Intractable Restless Legs Syndrome – Look for Other Causes. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.18177
402. Tavares, A., Dutra, T. L., & Daker, M. V. (2017). A relevância da síndrome das pernas inquietas (doença de willis-ekbom) para a prática clínica diária com pacientes com transtornos psiquiátricos. Debates em Psiquiatria. https://doi.org/10.25118/2763-9037.2017.v7.86
403. Teja, N., Gummadi, O. D., Devi, B. V., & Pavani, N. (2020). Evaluation of Depressant Activity on Mansoa alliacea on Rats. Acta Scientific Pharmaceutical Sciences. https://doi.org/10.31080/asps.2020.04.0617
404. Teng, S., Boo, A. Y. Y., & Lim, Z. W. (2023). Management of chronic non-cancer pain in primary care. Singapore Medical Journal. https://doi.org/10.4103/singaporemedj.smj-2021-126
405. Terrasa, S., & Piccirilli, M. V. (2009). Actualización: Síndrome de dolor regional complejo.
406. Thompson, W., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller‐Lissner, S. (1999). Functional bowel disorders and functional abdominal pain. Gut. https://doi.org/10.1136/gut.45.2008.ii43
407. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
408. Tintner, R., & Jankovic, J. (2007). Botulinum toxin. CRC Press eBooks. https://doi.org/10.3109/9780203640487-21
409. Torpy, J. M. (2008). Delirium. JAMA. https://doi.org/10.1001/jama.300.24.2936
410. Tran, K., & McCormack, S. (2020). Ketamine for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].
411. Trojanowska, M. (2017). Społeczny i medyczny wymiar seksualności osób z niepełnosprawnością na przykładzie osób chorych na stwardnienie rozsiane. Acta Universitatis Lodziensis Folia Sociologica. https://doi.org/10.18778/0208-600x.60.08
412. Trosch, R., Comella, C. L., Caroff, S. N., Ondo, W. G., Shillington, A. C., LaChappelle, B., Hauser, R. A., Correll, C. U., & Friedman, J. H. (2023). Reliability of the Clinician’s Tardive Inventory (CTI). CNS Spectrums. https://doi.org/10.1017/s1092852923001347
413. Truter, I. (2011). Irritable bowel syndrome.
414. Tsionos, I., & Viet, D. L. (2008). Nerve entrapment syndromes provoking motor deficits in the upper extremity. CRC Press eBooks. https://doi.org/10.3109/9780203091791-28
415. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
416. Tsuji, Y., Miyama, S., Uemura, Y., Kitanaka, N., Yoneda, A., Mikayama, H., Ohta, Y., Teramura, S., Sawaragi, S., Horikoshi, Y., Yamada, M., Matsu-ura, T., Kitade, H., Mori, T., Okuno, M., Ogura, T., & Takada, H. (2006). [Three cases of drug-induced akathisia due to antiemetics during cancer palliative care].. PubMed.
417. Turk, J., Graham, P. L., & Verhulst, F. C. (2007). Prevention and treatment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199216697.003.0009
418. Uitti, R. J. (2004). Orthostatic tremor (“shaky legs syndrome”). https://doi.org/10.1093/oso/9780195177442.003.0013
419. Ulfberg, J., Jönsson, R., Lindberg, E., Nyström, B., & Mallon, L. (1999). [Restless legs. A much neglected syndrome].. PubMed.
420. Unknown (2003). Anger Disorders. CRC Press eBooks. https://doi.org/10.1201/b14206-10
421. Unknown (2003). Managing patients with restless legs. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.2003.411181
422. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
423. Vallée, J.-P. (2010). Énurésie nocturne : informer/conseiller, évaluer, traiter. Médecine.
424. Vargas, A. P., Carod-Artal, F. J., Negro, M. C. D., & Rodrigues, M. P. C. (2000). Distonia psicogênica: relato de dois casos. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2000000300020
425. Vataja, R., & Leppävuori, A. (2012). [Assessment and treatment of conversion disorder: the most fascinating borderline of psychiatry and neurology].. PubMed.
426. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
427. Vlašić, K. M. (2016). Sestrinska skrb za bolesnike oboljele od depresivnog poremećaja.
428. Volder, I. D. (2006). Periodic limb movement disorder and restless legs syndrome. Breathe. https://doi.org/10.1183/18106838.0203.250
429. Vukić, V., Vidović, M., Harjaček, M., & Lamot, L. (2021). 449 The art of recognizing pain amplification syndrome in children. Abstracts. https://doi.org/10.1136/archdischild-2021-europaediatrics.449
430. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
431. Wakefield, J. C., & Schmitz, M. F. (2014). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry. https://doi.org/10.1002/wps.20155
432. Waldmann, C., Soni, N., & Rhodes, A. (2011). Neurological disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199229581.003.0022
433. Walker, M. C., & Sander, J. W. (2011). Epilepsy and Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/b13388-13
434. Walkup, J. T., & Schneider, B. (2008). Tourette’s Syndrome. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195309430.003.0020
435. Wallace, D. J., & Wallace, J. B. (2002). Are You Sure It’s Really Fibromyalgia?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195147537.003.0025
436. Walters, A. S., & Hamilton-Stubbs, P. (2011). Restless Legs Syndrome. https://doi.org/10.1002/9781444346183.ch20
437. Walters, A. S., & Zee, P. C. (2023). Why the worsening at rest and worsening at night criteria for Restless Legs Syndrome are listed separately: review of the circadian literature on RLS and suggestions for future directions. Frontiers in Neurology. https://doi.org/10.3389/fneur.2023.1153273
438. Walters, A. S., Aldrich, M. S., Allen, R. P., Ancoli‐Israel, S., Buchholz, D. W., Chokroverty, S., Coccagna, G., Earley, C. J., Ehrenberg, B. L., Feest, T., Hening, W. A., Kavey, N. B., Lavigne, G., Lipinski, J. F., Lugaresi, E., Montagna, P., Montplaisir, J., Mosko, S. S., Oertel, W. H., ... Zucconi, M. (1995). Toward a better definition of the restless legs syndrome. Movement Disorders. https://doi.org/10.1002/mds.870100517
439. Wilhelmsen, I. (2002). Somatization, sensitization, and functional dyspepsia. Scandinavian Journal of Psychology. https://doi.org/10.1111/1467-9450.00284
440. Williams, A. M. (2011). OP.02 Restless legs, periodic limb movements and breathing problems. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2011-300504.2
441. Willis, M. (2020). #WordsMatter—Communicating the voluntary‐to‐involuntary spectrum in conversion disorder. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30460
442. Wissow, L. S. (2021). Anxiety and Trauma-Related Distress. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396464
443. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
444. Yadin, E., & Foa, E. B. (2007). Cognitive Behavioral Treatments for Posttraumatic Stress Disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511500008.013
445. Yang, B.-K., Yi, S.-R., Ahn, Y.-J., Im, S. H., & Park, S. H. (2016). Ischial Tuberosity Avulsion Stress Fracture after Short Period of Repetitive Training. Hip & Pelvis. https://doi.org/10.5371/hp.2016.28.3.187
446. Yang, S. S., Seet, R. C., & Lim, E. C. (2010). Chewing-induced Facial Dystonia. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v39n9p740
447. Yu, G. V., Judge, M. S., Hudson, J. R., & Seidelmann, F. E. (2002). Predislocation Syndrome. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/87507315-92-4-182
448. Yuan, S. (2009). 不能解释的躯体症状的研究进展. Chin J Psychiatry. https://doi.org/10.3760/cma.j.issn.1006-7884.2009.03.019
449. Yılmaz, H., & Ak, A. K. (2016). Uykuda Seks Hastalığı. Journal of Turkish Sleep Medicine. https://doi.org/10.4274/jtsm.239
450. Zawilska, J. B., Santorek‐Strumiłło, E., & Kuna, P. (2010). [Nighttime eating disorders--clinical symptoms and treatment].. PubMed.
451. Zeller, J. L., Burke, A. E., & Glass, R. M. (2008). Acute Pain Treatment. JAMA. https://doi.org/10.1001/jama.299.1.128
452. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
453. Šrámková, T. (2017). Sexuální poruchy u nemocných s roztroušenou mozkomíšnísklerózou.
454. Živković, S., & Shipe, C. (2004). Electrodiagnostic Evaluation of Motor Neuron Disorders. American Journal of Electroneurodiagnostic Technology. https://doi.org/10.1080/1086508x.2004.11079458